https://www.pharmaceutical-business-review.com/news/wuxi-biologics-prima-sign-non-binding-mou-for-biologics-development-241116-5678596/ 2018-07-04T15:50:29+00:00 https://www.pharmaceutical-business-review.com/news/juno-therapeutics-places-leukemia-drug-trial-on-clinical-hold-241116-5678575/ 2018-07-04T15:50:29+00:00 https://www.pharmaceutical-business-review.com/news/d64b2nicox_completes_enrollment_in_phase_iii_osteoarthritis_/ 2018-07-04T15:50:30+00:00 https://www.pharmaceutical-business-review.com/news/neovacs-partners-with-3p-biopharmaceuticals-to-manufacture-interferon-alpha-cytokine-241116-5678533/ 2018-07-04T15:50:32+00:00 https://www.pharmaceutical-business-review.com/news/gsks-mepolizumab-meets-endpoints-in-phase-iii-egpa-trials-241116-5678424/ 2018-07-04T15:50:32+00:00 https://www.pharmaceutical-business-review.com/news/sun-pharma-to-buy-85-stake-in-russian-pharmaceutical-firm-biosintez-241116-5678269/ 2018-07-04T15:50:33+00:00 https://www.pharmaceutical-business-review.com/uncategorized/intarcia-seeks-us-approval-for-itca-650-to-treat-type-2-diabetes-231116-5677237/ 2018-07-04T15:50:36+00:00 https://www.pharmaceutical-business-review.com/news/globaldata-says-non-small-cell-lung-cancer-market-to-gain-over-20-billion-in-value-by-2025-5677207/ 2018-07-04T15:50:36+00:00 https://www.pharmaceutical-business-review.com/news/eli-lillys-alzheimers-drug-fails-in-phase-3-trial-241116-5678252/ 2018-07-04T15:50:36+00:00 https://www.pharmaceutical-business-review.com/uncategorized/astrazeneca-resumes-patient-enrolment-as-fda-lifts-partial-clinical-hold-on-hnscc-trials-231116-5677138/ 2018-07-04T15:50:39+00:00 https://www.pharmaceutical-business-review.com/news/allergan-acquires-chase-pharmaceuticals-221116-5677098/ 2018-07-04T15:50:39+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-squibbs-opdivo-approved-for-hodgkin-lymphoma-in-europe-231116-5676797/ 2018-07-04T15:50:40+00:00 https://www.pharmaceutical-business-review.com/uncategorized/biolinerx-secures-rights-to-des-candidate-from-hebrew-university-5675714/ 2018-07-04T15:50:43+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-darzalex-for-relapsed-multiple-myeloma-221116-5675681/ 2018-07-04T15:50:44+00:00 https://www.pharmaceutical-business-review.com/news/novartis-acquires-selexys-to-expand-hematology-pipeline-221116-5675495/ 2018-07-04T15:50:44+00:00 https://www.pharmaceutical-business-review.com/news/diurnal-doses-first-patient-in-native-oral-testosterone-formulation-phase-i-trial-221116-5675508/ 2018-07-04T15:50:48+00:00 https://www.pharmaceutical-business-review.com/news/tevas-trisenox-approved-in-europe-for-first-line-treatment-of-apl-221116-5675356/ 2018-07-04T15:50:48+00:00 https://www.pharmaceutical-business-review.com/news/tillotts-introduces-new-technology-for-colonic-targeting-of-active-molecules-211116-5674225/ 2018-07-04T15:50:48+00:00 https://www.pharmaceutical-business-review.com/uncategorized/fda-scientists-develop-new-mouse-model-for-zika-studies-211116-5674201/ 2018-07-04T15:50:52+00:00 https://www.pharmaceutical-business-review.com/news/pharmakea-celgene-expand-fibrotic-disease-therapy-partnership-211116-5674167/ 2018-07-04T15:50:52+00:00 https://www.pharmaceutical-business-review.com/news/stealths-mitochondrial-dysfunction-drug-meets-phase-2-endpoints-211116-5674109/ 2018-07-04T15:50:53+00:00 https://www.pharmaceutical-business-review.com/news/fda-extends-indication-for-gsks-flulaval-quadrivalent-influenza-vaccine-in-infants-211116-5673985/ 2018-07-04T15:50:56+00:00 https://www.pharmaceutical-business-review.com/news/biospecifics-says-phase-2b-study-of-cch-succeeds-in-patients-with-cellulite-181116-5672972/ 2018-07-04T15:50:56+00:00 https://www.pharmaceutical-business-review.com/news/us-ftc-issues-enforcement-policy-statement-on-marketing-claims-for-otc-homeopathic-drugs-181116-5672858/ 2018-07-04T15:50:56+00:00 https://www.pharmaceutical-business-review.com/news/immune-pharmaceuticals-secures-up-to-11m-in-new-financing-181116-5672836/ 2018-07-04T15:51:00+00:00 https://www.pharmaceutical-business-review.com/news/medimmune-completes-out-licensing-agreement-with-allergan-for-medi2070-5672825/ 2018-07-04T15:51:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/janssen-seeks-us-approval-for-guselkumab-to-treat-plaque-psoriasis-181116-5672645/ 2018-07-04T15:51:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-gsks-ra-treatment-sirukumab-demonstrates-mixed-results-against-abbvies-humira-171116-5671569/ 2018-07-04T15:51:04+00:00 https://www.pharmaceutical-business-review.com/news/amplyxs-apx001-gets-fda-orphan-drug-status-to-treat-multiple-invasive-fungal-infections-171116-5671343/ 2018-07-04T15:51:04+00:00 https://www.pharmaceutical-business-review.com/news/grnenthal-acquires-us-based-thar-pharmaceuticals-171116-5671331/ 2018-07-04T15:51:05+00:00 https://www.pharmaceutical-business-review.com/news/874baoramed_initiates_phase_iia_trials_on_type_1_diab/ 2018-07-04T15:51:07+00:00 https://www.pharmaceutical-business-review.com/news/ed496chembridge_and_astrazeneca_partner_in_drug_disc/ 2018-07-04T15:51:08+00:00 https://www.pharmaceutical-business-review.com/news/1f4bcm_d_anderson_cancer_center_selects_instems_provantis_preclinical_sof/ 2018-07-04T15:51:08+00:00 https://www.pharmaceutical-business-review.com/news/4448e454_life_sciences_and_idt_sign_agreement_for_primer_design_and_s/ 2018-07-04T15:51:08+00:00 https://www.pharmaceutical-business-review.com/news/9d4b4scolr_pharma_obtains_31_million_lease_termination_pa/ 2018-07-04T15:51:08+00:00 https://www.pharmaceutical-business-review.com/news/tnk-therapeutics-enters-into-binding-term-sheet-to-buy-virttu-biologics-171116-5671322/ 2018-07-04T15:51:10+00:00 https://www.pharmaceutical-business-review.com/news/summit-therapeutics-enrols-first-us-patients-in-ezutromid-trial-for-dmd-5671316/ 2018-07-04T15:51:10+00:00 https://www.pharmaceutical-business-review.com/news/amgens-erenumab-succeeds-in-second-phase-3-migraine-study-171116-5671127/ 2018-07-04T15:51:10+00:00 https://www.pharmaceutical-business-review.com/uncategorized/janssens-guselkumab-found-safe-for-treatment-of-psoriatic-arthritis-in-phase-2-study-5670527/ 2018-07-04T15:51:13+00:00 https://www.pharmaceutical-business-review.com/uncategorized/selexis-ose-partner-to-advance-immunotherapies-development-for-cancer-diseases-161116-5670501/ 2018-07-04T15:51:13+00:00 https://www.pharmaceutical-business-review.com/news/iv-administered-ganaxolone-and-diazepam-synergistically-block-seizures-in-animal-model-of-se-5670463/ 2018-07-04T15:51:14+00:00 https://www.pharmaceutical-business-review.com/news/e4485transenterix_names_new_president_an/ 2018-07-04T15:51:15+00:00 https://www.pharmaceutical-business-review.com/news/084b2ge_healthcare_forms_partnership_with_living_independently_/ 2018-07-04T15:51:15+00:00 https://www.pharmaceutical-business-review.com/news/fd4acarpida_completes_enrollment_in_phase_ii_csssi_/ 2018-07-04T15:51:15+00:00 https://www.pharmaceutical-business-review.com/uncategorized/albireos-lead-product-candidate-for-orphan-pediatric-liver-disease-accepted-into-emas-prime-program-5670441/ 2018-07-04T15:51:16+00:00 https://www.pharmaceutical-business-review.com/news/abbvies-pan-genotypic-hepatitis-c-test-drug-regimen-succeeds-in-phase-3-trial-161116-5669835/ 2018-07-04T15:51:16+00:00 https://www.pharmaceutical-business-review.com/news/braeburn-says-phase-3-trial-for-injectable-opioid-dependence-treatment-succeeds-5669043/ 2018-07-04T15:51:16+00:00 https://www.pharmaceutical-business-review.com/news/6a4b0polymedix_raises_425_million_in_fina/ 2018-07-04T15:51:16+00:00 https://www.pharmaceutical-business-review.com/news/064b5biospecifics_technologies_names_new_board_m/ 2018-07-04T15:51:16+00:00 https://www.pharmaceutical-business-review.com/news/73484ppd_confirms_takedas_nda_submission_of_diabetes_drugs_t/ 2018-07-04T15:51:20+00:00 https://www.pharmaceutical-business-review.com/news/a3482ligand_to_acquire_pharmac/ 2018-07-04T15:51:20+00:00 https://www.pharmaceutical-business-review.com/news/0249ebracco_and_lantheus_medical_sign_copromotion_agre/ 2018-07-04T15:51:20+00:00 https://www.pharmaceutical-business-review.com/news/844bdsyneron_wins_fda_clearance_for_matrix_rf_ablative_appli/ 2018-07-04T15:51:20+00:00 https://www.pharmaceutical-business-review.com/news/mesoblast-unveils-successful-interim-futility-analysis-in-phase-3-trial-for-agvhd-151116-5668929/ 2018-07-04T15:51:20+00:00 https://www.pharmaceutical-business-review.com/news/midatech-pharma-selects-mtr104-candidate-for-liver-cancer-treatment-151116-5668913/ 2018-07-04T15:51:20+00:00 https://www.pharmaceutical-business-review.com/news/parexel-launches-idmp-focused-software-solution-for-biopharmaceutical-firms-151116-5668889/ 2018-07-04T15:51:20+00:00 https://www.pharmaceutical-business-review.com/news/70483grameen_health_to_form_partnerships_with_big_p/ 2018-07-04T15:51:21+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-priority-review-to-novartis-pkc412-for-aml-and-mastocytosis-151116-5668610/ 2018-07-04T15:51:24+00:00 https://www.pharmaceutical-business-review.com/news/964absequenom_to_acquire_center_for_molecular_med/ 2018-07-04T15:51:25+00:00 https://www.pharmaceutical-business-review.com/news/de4bdquatrx_reports_additional_results_from_phase_iii_vaginal_atrophy_/ 2018-07-04T15:51:25+00:00 https://www.pharmaceutical-business-review.com/news/c14abanadys_reports_positive_preliminary_results_from_phase_i_hepatitis_/ 2018-07-04T15:51:25+00:00 https://www.pharmaceutical-business-review.com/news/c9483merck_serono_reports_encouraging_onemonth_results_from_ghd_/ 2018-07-04T15:51:25+00:00 https://www.pharmaceutical-business-review.com/news/amgens-parsabiv-approved-in-europe-for-shpt-treatment-in-adults-with-ckd-141116-5667780/ 2018-07-04T15:51:25+00:00 https://www.pharmaceutical-business-review.com/news/corvus-unveils-preliminary-phase-11b-clinical-data-with-cpi-444-demonstrating-safety-and-evidence-of-anti-tumor-activity-as-single-agent-in-advanced-refractory-cancers-5667631/ 2018-07-04T15:51:25+00:00 https://www.pharmaceutical-business-review.com/news/164bebial_reports_positive_results_from_phase_iii_studies_of_seizure/ 2018-07-04T15:51:26+00:00 https://www.pharmaceutical-business-review.com/news/87490lonza_and_crucell_sign_agreement_for_permexcis_cell_culture_m/ 2018-07-04T15:51:29+00:00 https://www.pharmaceutical-business-review.com/news/81498anthera_reaches_agreement_with_fda_for_phase_iii_protocol_of_coronary/ 2018-07-04T15:51:30+00:00 https://www.pharmaceutical-business-review.com/news/624b8miraculins_signs_loi_with_mount_sinai_ser/ 2018-07-04T15:51:30+00:00 https://www.pharmaceutical-business-review.com/news/804bcobs_medical_wins_fda_clearance_for_vitalalert_techn/ 2018-07-04T15:51:30+00:00 https://www.pharmaceutical-business-review.com/news/72491polymedix_initiates_dosing_in_phase_i_study_of_anticoagulant_com/ 2018-07-04T15:51:30+00:00 https://www.pharmaceutical-business-review.com/news/chmp-issues-positive-opinion-recommending-suliquatm-iglarlixi-for-approval-5667614/ 2018-07-04T15:51:30+00:00 https://www.pharmaceutical-business-review.com/news/eagle-pharmaceuticals-agrees-to-buy-arsia-therapeutics-141116-5667603/ 2018-07-04T15:51:30+00:00 https://www.pharmaceutical-business-review.com/news/pfizers-celebrex-found-to-be-no-riskier-for-hearts-than-other-rival-pain-drugs-141116-5667266/ 2018-07-04T15:51:30+00:00 https://www.pharmaceutical-business-review.com/news/pfizers-breast-cancer-drug-ibrance-gets-ec-approval-111116-5666443/ 2018-07-04T15:51:33+00:00 https://www.pharmaceutical-business-review.com/news/2a4b3zabecor_announces_formation_of_new_subsi/ 2018-07-04T15:51:34+00:00 https://www.pharmaceutical-business-review.com/news/32480cryocell_announces_global_expansion_of_c/ 2018-07-04T15:51:34+00:00 https://www.pharmaceutical-business-review.com/news/elcelyx-unveils-positive-results-in-phase-2b-study-of-metformin-dr-in-type-2-diabetes-111116-5666207/ 2018-07-04T15:51:34+00:00 https://www.pharmaceutical-business-review.com/news/amgen-partners-with-janssen-to-co-fund-studies-with-kyprolis-and-darzalex-in-multiple-myeloma-patients-5666174/ 2018-07-04T15:51:34+00:00 https://www.pharmaceutical-business-review.com/news/394b6inspire_initiates_special_protocol_assessment_process_for_dry_eye_/ 2018-07-04T15:51:35+00:00 https://www.pharmaceutical-business-review.com/news/b349dcoti_to_advance_six_drug_candidates_from_hiv_drug_pr/ 2018-07-04T15:51:35+00:00 https://www.pharmaceutical-business-review.com/news/65482martek_signs_sole_source_supply_agreement_with_grupo_/ 2018-07-04T15:51:35+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-gileads-vemlidy-to-treat-chronic-hepatitis-b-virus-infection-5666067/ 2018-07-04T15:51:36+00:00 https://www.pharmaceutical-business-review.com/news/ibm-watson-broad-institute-partner-on-50m-cancer-drug-resistance-project-111116-5666045/ 2018-07-04T15:51:36+00:00 https://www.pharmaceutical-business-review.com/news/regenerx-enrolls-first-patients-in-phase-3-us-dry-eye-clinical-trial-with-rgn-259-101116-5664925/ 2018-07-04T15:51:37+00:00 https://www.pharmaceutical-business-review.com/news/11498alimeras_phase_iii_dme_trials_receive_positive_review_from/ 2018-07-04T15:51:38+00:00 https://www.pharmaceutical-business-review.com/news/534b2iflow_wins_clearance_for_oxygenated_topical_wound_dre/ 2018-07-04T15:51:38+00:00 https://www.pharmaceutical-business-review.com/news/d5483cornerstone_pharmaceuticals_initiates_dosing_in_cancer_/ 2018-07-04T15:51:38+00:00 https://www.pharmaceutical-business-review.com/news/4d496asterion_signs_research_and_option_agreement_with_ge/ 2018-07-04T15:51:39+00:00 https://www.pharmaceutical-business-review.com/news/814b7affitech_achieves_second_milestone_in_roche_antibody_discovery_collabor/ 2018-07-04T15:51:39+00:00 https://www.pharmaceutical-business-review.com/news/vitality-biopharma-seeks-patent-for-cannabinoid-pharmaceuticals-5664888/ 2018-07-04T15:51:40+00:00 https://www.pharmaceutical-business-review.com/news/sorrento-therapeutics-completes-scilex-acquisition-101116-5664847/ 2018-07-04T15:51:40+00:00 https://www.pharmaceutical-business-review.com/news/fda-lifts-partial-clinical-hold-on-adaptimmunes-study-of-t-cell-therapy-in-mrcls-101116-5664894/ 2018-07-04T15:51:40+00:00 https://www.pharmaceutical-business-review.com/news/4348crbc_life_sciences_names_new_dir/ 2018-07-04T15:51:42+00:00 https://www.pharmaceutical-business-review.com/news/2d4bfadvanced_medical_optics_appoints_new_director_of_microbi/ 2018-07-04T15:51:43+00:00 https://www.pharmaceutical-business-review.com/news/f24badiogenix_spins_off_from_parent_co/ 2018-07-04T15:51:43+00:00 https://www.pharmaceutical-business-review.com/news/f94a8palatin_technologiess_phase_i_heart_failure_trial_meets_end/ 2018-07-04T15:51:43+00:00 https://www.pharmaceutical-business-review.com/news/f94b1takeda_files_nda_for_diabetes/ 2018-07-04T15:51:43+00:00 https://www.pharmaceutical-business-review.com/uncategorized/dnatrix-licenses-myxoma-virus-for-new-immunotherapy-platform-101116-5664835/ 2018-07-04T15:51:44+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-infinity-partner-for-opdivo-ipi-549-combo-trial-in-advanced-solid-tumors-101116-5664613/ 2018-07-04T15:51:44+00:00 https://www.pharmaceutical-business-review.com/uncategorized/researchers-discover-monobody-that-can-potentially-fight-30-of-cancers-091116-5663383/ 2018-07-04T15:51:45+00:00 https://www.pharmaceutical-business-review.com/news/9a4b9phosphagenics_initiates_phase_i_pain_/ 2018-07-04T15:51:47+00:00 https://www.pharmaceutical-business-review.com/news/024b1tevas_albuterol_inhaler_wins_new_pediatric_indic/ 2018-07-04T15:51:47+00:00 https://www.pharmaceutical-business-review.com/news/8848aimarx_therapeutics_sells_urokinase_business_to_microbix_biosy/ 2018-07-04T15:51:47+00:00 https://www.pharmaceutical-business-review.com/news/234babristolmyers_squibb_reports_positive_survival_data_from_phase_iii_cancer_/ 2018-07-04T15:51:48+00:00 https://www.pharmaceutical-business-review.com/news/a449dsanofiaventis_wins_fda_approval_for_nasacort_aq_nasal_/ 2018-07-04T15:51:48+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-to-review-emmaus-life-sciences-nda-for-sickle-cell-disease-091116-5663333/ 2018-07-04T15:51:49+00:00 https://www.pharmaceutical-business-review.com/news/uk-artificial-intelligence-firm-secures-rights-to-several-janssen-drug-candidates-091116-5663307/ 2018-07-04T15:51:49+00:00 https://www.pharmaceutical-business-review.com/news/seattle-genetics-takeda-complete-enrollment-in-phase-3-trial-of-adcetris-in-frontline-mature-t-cell-lymphoma-091116-5663284/ 2018-07-04T15:51:49+00:00 https://www.pharmaceutical-business-review.com/news/ab4bdmercks_phase_iiib_multiple_sclerosis_study_meets_end/ 2018-07-04T15:51:51+00:00 https://www.pharmaceutical-business-review.com/news/534a8arteriocyte_wins_nih_fast_track_grant_for_critical_limb_ischemia_res/ 2018-07-04T15:51:51+00:00 https://www.pharmaceutical-business-review.com/news/e74a4akesis_expands_preclinical_safety_program_for_diabetes/ 2018-07-04T15:51:51+00:00 https://www.pharmaceutical-business-review.com/news/734aezila_selects_dentalmed_to_distribute_oral_cancer_screening_product_in_r/ 2018-07-04T15:51:52+00:00 https://www.pharmaceutical-business-review.com/news/9d4a2angiotech_announces_cost_cutting_/ 2018-07-04T15:51:52+00:00 https://www.pharmaceutical-business-review.com/news/biocon-mylan-seek-fda-approval-for-trastuzumab-biosimilar-091116-5663059/ 2018-07-04T15:51:53+00:00 https://www.pharmaceutical-business-review.com/news/bayer-seeks-fda-approval-for-regorafenib-in-treating-liver-cancer-081116-5661957/ 2018-07-04T15:51:53+00:00 https://www.pharmaceutical-business-review.com/news/geovax-viamune-to-partner-on-cancer-immunotherapy-program-081116-5661908/ 2018-07-04T15:51:53+00:00 https://www.pharmaceutical-business-review.com/news/72492ge_signs_rd_agreement_with_national_cancer_inst/ 2018-07-04T15:51:55+00:00 https://www.pharmaceutical-business-review.com/news/8d4a2bristolmyers_squibb_raises_imclon/ 2018-07-04T15:51:55+00:00 https://www.pharmaceutical-business-review.com/news/8e4a9crucell_wins_new_contracts_for_quinvaxem_and_hepavax/ 2018-07-04T15:51:55+00:00 https://www.pharmaceutical-business-review.com/news/9c498kiadis_pharma_wins_orphan_drug_designation_for_transplant/ 2018-07-04T15:51:55+00:00 https://www.pharmaceutical-business-review.com/news/1e4adorexo_confirms_uk_marketing_approval_for_cancer_pain/ 2018-07-04T15:51:56+00:00 https://www.pharmaceutical-business-review.com/news/lexicon-acquires-rights-to-pain-candidate-developed-with-bms-5661833/ 2018-07-04T15:51:56+00:00 https://www.pharmaceutical-business-review.com/news/amryt-secures-fda-orphan-drug-designation-for-acromegaly-compound-081116-5661809/ 2018-07-04T15:51:57+00:00 https://www.pharmaceutical-business-review.com/news/biogen-and-ionis-spinal-muscular-atrophy-treatment-meets-primary-endpoint-in-phase-3-study-081116-5661494/ 2018-07-04T15:51:57+00:00 https://www.pharmaceutical-business-review.com/news/nestle-health-science-to-invest-145m-in-aimmune-on-food-allergy-therapies-071116-5660103/ 2018-07-04T15:52:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-status-for-abbvies-veliparib-to-treat-advanced-squamous-nsclc-071116-5659977/ 2018-07-04T15:52:01+00:00 https://www.pharmaceutical-business-review.com/news/4649cgemin_x_granted_new_us_patent_for_cancer/ 2018-07-04T15:52:07+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-genzyme-starts-phase-3-trial-of-neogaa-investigational-second-generation-therapy-for-pompe-disease-5659940/ 2018-07-04T15:52:07+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-amgens-enbrel-to-treat-children-with-plaque-psoriasis-071116-5659881/ 2018-07-04T15:52:07+00:00 https://www.pharmaceutical-business-review.com/news/enbiotix-closes-acquisition-of-amp-therapeutics-041116-5658889/ 2018-07-04T15:52:07+00:00 https://www.pharmaceutical-business-review.com/news/844acarisyn_acquires_portfolio_of_small_molecule_inhibitors_fro/ 2018-07-04T15:52:08+00:00 https://www.pharmaceutical-business-review.com/news/394b7inspiremd_initiates_enrollment_in_acute_myocardial_infarction_/ 2018-07-04T15:52:08+00:00 https://www.pharmaceutical-business-review.com/news/d84accovidien_wins_fda_approval_for_generic_myocardial_perfusion_imagin/ 2018-07-04T15:52:08+00:00 https://www.pharmaceutical-business-review.com/news/ee482neotropix_names_ne/ 2018-07-04T15:52:09+00:00 https://www.pharmaceutical-business-review.com/news/mereo-biopharma-reports-positive-results-for-acumapimod-phase-1-drug-study-041116-5658863/ 2018-07-04T15:52:11+00:00 https://www.pharmaceutical-business-review.com/news/european-regulator-accepts-to-review-mylans-maa-for-insulin-glargine-041116-5658767/ 2018-07-04T15:52:11+00:00 https://www.pharmaceutical-business-review.com/news/c0497kalobios_pharmaceuticals_raises_20_million_in_series_d_fina/ 2018-07-04T15:52:12+00:00 https://www.pharmaceutical-business-review.com/news/cannabis-science-to-start-in-house-clinical-research-with-igxbios-genepro-fda-ind-number-015982-5658691/ 2018-07-04T15:52:12+00:00 https://www.pharmaceutical-business-review.com/news/054a4wyeth_initiates_pneumonia_vaccine_/ 2018-07-04T15:52:13+00:00 https://www.pharmaceutical-business-review.com/news/6e4a1nicox_signs_manufacturing_agreement_with_cap/ 2018-07-04T15:52:13+00:00 https://www.pharmaceutical-business-review.com/news/b349dastrazeneca_announces_key_ruling_in_asthma_drug_patent_litig/ 2018-07-04T15:52:13+00:00 https://www.pharmaceutical-business-review.com/news/e0497arcxis_and_roche_molecular_systems_initiate_research_collabor/ 2018-07-04T15:52:13+00:00 https://www.pharmaceutical-business-review.com/news/researchers-engineer-antimicrobial-peptide-to-kill-bacteria-041116-5658582/ 2018-07-04T15:52:14+00:00 https://www.pharmaceutical-business-review.com/news/turnstone-raises-414m-for-developing-immunotherapy-compound-031116-5657208/ 2018-07-04T15:52:15+00:00 https://www.pharmaceutical-business-review.com/news/aurinia-unveils-plans-for-single-phase-iii-trial-for-voclosporin-in-treatment-of-lupus-nephritis-5657160/ 2018-07-04T15:52:15+00:00 https://www.pharmaceutical-business-review.com/news/4f4b3aveo_pharmaceuticals_initiates_phase_i_lymphoma_/ 2018-07-04T15:52:16+00:00 https://www.pharmaceutical-business-review.com/news/0c494oriel_therapeutics_names_ne/ 2018-07-04T15:52:16+00:00 https://www.pharmaceutical-business-review.com/news/284afimpulse_monitoring_and_legacy_emanuel_sign_ionm_services_agre/ 2018-07-04T15:52:16+00:00 https://www.pharmaceutical-business-review.com/news/e249bkuros_and_aeris_sign_licensing_agre/ 2018-07-04T15:52:16+00:00 https://www.pharmaceutical-business-review.com/news/2f49esun_pharmaceutical_wins_fda_approval_for_cancer_drugs/ 2018-07-04T15:52:17+00:00 https://www.pharmaceutical-business-review.com/news/two-clinical-stage-oncology-programs-from-tetralogic-pharmaceuticals-5657148/ 2018-07-04T15:52:18+00:00 https://www.pharmaceutical-business-review.com/news/ers-genomics-agrees-to-license-crisprcas9-to-knudra-transgenics-5657136/ 2018-07-04T15:52:18+00:00 https://www.pharmaceutical-business-review.com/news/baxter-launches-phase-3-trial-of-new-therapy-for-acute-kidney-injury-031116-5656881/ 2018-07-04T15:52:18+00:00 https://www.pharmaceutical-business-review.com/news/404b2osiris_completes_enrollment_for_pulmonary_disease_/ 2018-07-04T15:52:19+00:00 https://www.pharmaceutical-business-review.com/news/fc498luminex_and_bd_sign_supply_and_development_agre/ 2018-07-04T15:52:20+00:00 https://www.pharmaceutical-business-review.com/news/e24bfmetabasis_therapeutics_initiates_diabetes_/ 2018-07-04T15:52:20+00:00 https://www.pharmaceutical-business-review.com/news/7b49dsorin_group_initiates_patient_enrollment_in_eoptima_reg/ 2018-07-04T15:52:20+00:00 https://www.pharmaceutical-business-review.com/news/e04bfbioms_medical_receives_10_million_milestone_payment_from_/ 2018-07-04T15:52:20+00:00 https://www.pharmaceutical-business-review.com/news/c448asequenom_signs_licensing_agreement_with_genomic_nanosy/ 2018-07-04T15:52:23+00:00 https://www.pharmaceutical-business-review.com/news/1a4a6encorium_postpones_acquisition_negotiations_with_pro/ 2018-07-04T15:52:23+00:00 https://www.pharmaceutical-business-review.com/news/4f4a9omrix_completes_enrollment_of_90_patients_in_phase_ii_fibrin_pad_/ 2018-07-04T15:52:24+00:00 https://www.pharmaceutical-business-review.com/news/ef4b0durect_licenses_eladur_pain_patch_to_alp/ 2018-07-04T15:52:24+00:00 https://www.pharmaceutical-business-review.com/news/054a9nanobiotix_wins_patent_for_nanoxray_anticancer_pla/ 2018-07-04T15:52:24+00:00 https://www.pharmaceutical-business-review.com/news/88483ariad_announces_disappointing_ruling_from_amgen_patent_infringement_la/ 2018-07-04T15:52:28+00:00 https://www.pharmaceutical-business-review.com/news/4648ftengion_gets_expanded_orphan_designation_for_neobladder_au/ 2018-07-04T15:52:28+00:00 https://www.pharmaceutical-business-review.com/news/e24bbastrazeneca_granted_sixmonth_pediatric_exclusivity_for_prostate_cancer/ 2018-07-04T15:52:28+00:00 https://www.pharmaceutical-business-review.com/news/fda-gives-priority-review-status-to-novartis-breast-cancer-drug-021116-5656121/ 2018-07-04T15:52:28+00:00 https://www.pharmaceutical-business-review.com/news/allergan-completes-acquisition-of-tobira-therapeutics-021116-5656006/ 2018-07-04T15:52:28+00:00 https://www.pharmaceutical-business-review.com/news/05487zentiva_accepts_26_billion_offer_from_sanofiav/ 2018-07-04T15:52:29+00:00 https://www.pharmaceutical-business-review.com/news/63487ico_therapeutics_reports_encouraging_interim_results_from_phase_i_edema_/ 2018-07-04T15:52:29+00:00 https://www.pharmaceutical-business-review.com/news/portola-expands-collaboration-with-daiichi-to-develop-andexxa-in-germany-021116-5655979/ 2018-07-04T15:52:29+00:00 https://www.pharmaceutical-business-review.com/news/nimbus-secures-200m-from-gilead-for-inhibitor-program-acquisition-021116-5655942/ 2018-07-04T15:52:32+00:00 https://www.pharmaceutical-business-review.com/news/164a8cytrx_acquires_innovive_pharmaceut/ 2018-07-04T15:52:33+00:00 https://www.pharmaceutical-business-review.com/news/6e4bdcryolife_expands_distribution_of_hemostase_mph_in_c/ 2018-07-04T15:52:33+00:00 https://www.pharmaceutical-business-review.com/news/7c494baxter_initiates_phase_iii_alzheimers_/ 2018-07-04T15:52:33+00:00 https://www.pharmaceutical-business-review.com/news/c04bdnovartis_and_nordic_complete_enrollment_for_phase_iii_osteoarthritis_/ 2018-07-04T15:52:33+00:00 https://www.pharmaceutical-business-review.com/news/celgene-and-ibm-watson-to-develop-new-offering-in-patient-safety-monitoring-021116-5655895/ 2018-07-04T15:52:33+00:00 https://www.pharmaceutical-business-review.com/news/valeant-in-talks-to-divest-gastroenterology-business-unit-021116-5655403/ 2018-07-04T15:52:33+00:00 https://www.pharmaceutical-business-review.com/news/6e482mylan_wins_fda_approval_for_parkinsons/ 2018-07-04T15:52:34+00:00 https://www.pharmaceutical-business-review.com/news/aralez-acquires-us-rights-to-astrazeneca-high-blood-pressure-drug-toprol-xl-011116-5654322/ 2018-07-04T15:52:35+00:00 https://www.pharmaceutical-business-review.com/uncategorized/acadia-pharmaceuticals-starts-phase-ii-study-of-pimavanserin-in-alzheimers-disease-agitation-011116-5654274/ 2018-07-04T15:52:35+00:00 https://www.pharmaceutical-business-review.com/uncategorized/catalyst-receives-spa-from-the-fda-for-second-phase-3-trial-assessing-firdapse-to-treat-lems-011116-5654262/ 2018-07-04T15:52:35+00:00 https://www.pharmaceutical-business-review.com/news/654aevion_signs_agreement_with_institut_paolicalm/ 2018-07-04T15:52:37+00:00 https://www.pharmaceutical-business-review.com/news/b5496biolase_granted_new_japanese_p/ 2018-07-04T15:52:37+00:00 https://www.pharmaceutical-business-review.com/news/d84a8javelin_initiates_enrollment_for_phase_iii_pain_/ 2018-07-04T15:52:37+00:00 https://www.pharmaceutical-business-review.com/news/d848bhelix_wins_approval_to_open_clinical_sites_in_ge/ 2018-07-04T15:52:37+00:00 https://www.pharmaceutical-business-review.com/news/14493ikonisys_launches_new_cervical_cancer/ 2018-07-04T15:52:38+00:00 https://www.pharmaceutical-business-review.com/uncategorized/therapix-completes-formulation-development-for-tablet-for-sublingual-administration-of-pharmaceutical-use-011116-5654252/ 2018-07-04T15:52:39+00:00 https://www.pharmaceutical-business-review.com/uncategorized/ema-validates-avelumab-maa-for-rare-skin-cancer-01116-5653947/ 2018-07-04T15:52:40+00:00 https://www.pharmaceutical-business-review.com/news/setback-for-sanofi-and-regeneron-as-fda-delays-ra-drug-approval-311016-5652570/ 2018-07-04T15:52:40+00:00 https://www.pharmaceutical-business-review.com/news/e64bderagen_receives_health_canada_approval_for_five_molecular_test_produ/ 2018-07-04T15:52:44+00:00 https://www.pharmaceutical-business-review.com/news/ec-grants-orphan-drug-designation-to-philogens-soft-tissue-sarcoma-treatment-311016-5652443/ 2018-07-04T15:52:44+00:00 https://www.pharmaceutical-business-review.com/news/e149fatrium_innovations_acquires_orthos_e/ 2018-07-04T15:52:45+00:00 https://www.pharmaceutical-business-review.com/news/9a4bcteva_launches_nicardipine_hcl_injection_/ 2018-07-04T15:52:45+00:00 https://www.pharmaceutical-business-review.com/news/ema-accepts-to-evaluate-pharmamars-maa-for-aplidin-311016-5652425/ 2018-07-04T15:52:45+00:00 https://www.pharmaceutical-business-review.com/news/454b4sciclone_reports_encouraging_results_from_phase_iia_hepatitis_/ 2018-07-04T15:52:45+00:00 https://www.pharmaceutical-business-review.com/news/eisai-starts-two-phase-iii-studies-for-antiepileptic-drug-perampanel-311016-5652379/ 2018-07-04T15:52:45+00:00 https://www.pharmaceutical-business-review.com/news/59490genmab_completes_recruitment_for_phase_ii_lymphoma_/ 2018-07-04T15:52:45+00:00 https://www.pharmaceutical-business-review.com/news/astellas-to-acquire-ganymed-pharmaceuticals-in-eur128bn-deal-311016-5652344/ 2018-07-04T15:52:47+00:00 https://www.pharmaceutical-business-review.com/news/allergan-exercises-option-to-buy-motus-therapeutics-281016-5651600/ 2018-07-04T15:52:48+00:00 https://www.pharmaceutical-business-review.com/news/inositec-ag-secures-chf14-million-in-seed-financing-to-advance-new-class-of-inositol-hexaphosphate-based-drug-candidates-5651462/ 2018-07-04T15:52:48+00:00 https://www.pharmaceutical-business-review.com/news/0a4bbosmetech_and_qiagen_sign_development_and_supply_agre/ 2018-07-04T15:52:50+00:00 https://www.pharmaceutical-business-review.com/news/eb4b3labopharm_files_nda_for_depression/ 2018-07-04T15:52:50+00:00 https://www.pharmaceutical-business-review.com/news/d94a1map_pharmaceuticals_completes_enrollment_for_phase_iii_asthma_/ 2018-07-04T15:52:51+00:00 https://www.pharmaceutical-business-review.com/news/proqrs-qr-010-meets-primary-endpoint-in-proof-of-concept-study-of-homozygous-f508del-cystic-fibrosis-patients-5651429/ 2018-07-04T15:52:51+00:00 https://www.pharmaceutical-business-review.com/news/c64bboxygen_biotherapeutics_signs_licensing_agreement_with_glucome/ 2018-07-04T15:52:51+00:00 https://www.pharmaceutical-business-review.com/news/b8488regenerx_and_sigmatau_complete_enrollment_for_phase_ii_ulcer_/ 2018-07-04T15:52:51+00:00 https://www.pharmaceutical-business-review.com/news/adamas-submits-new-drug-application-to-fda-for-ads-5102-281016-5651415/ 2018-07-04T15:52:52+00:00 https://www.pharmaceutical-business-review.com/uncategorized/fda-places-partial-hold-on-astrazenecas-two-cancer-drug-trials-281016-5651193/ 2018-07-04T15:52:52+00:00 https://www.pharmaceutical-business-review.com/news/d0493dynavax_receives_45_million_milestone_payment_from_astraz/ 2018-07-04T15:52:54+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheims-humira-biosimilar-candidate-succeeds-in-rheumatoid-arthritis-study-271016-5650075/ 2018-07-04T15:52:54+00:00 https://www.pharmaceutical-business-review.com/news/oncogenex-unveils-positive-survival-results-from-apatorsen-phase-2-borealis-2-trial-in-metastatic-bladder-cancer-5649991/ 2018-07-04T15:52:54+00:00 https://www.pharmaceutical-business-review.com/news/be4b1biopartners_reports_encouraging_data_from_phase_iiiii_ghd_/ 2018-07-04T15:52:55+00:00 https://www.pharmaceutical-business-review.com/news/ifm-therapeutics-establishes-german-subsidiary-and-research-site-in-bonn-271016-5649954/ 2018-07-04T15:52:55+00:00 https://www.pharmaceutical-business-review.com/news/c54banapo_reports_positive_results_from_cholera_/ 2018-07-04T15:52:55+00:00 https://www.pharmaceutical-business-review.com/news/6648dregenerx_initiates_enrollment_for_phase_ib_acute_myocardial_infarction_/ 2018-07-04T15:52:55+00:00 https://www.pharmaceutical-business-review.com/news/d34a7anika_signs_distribution_agreement_with_depuy_/ 2018-07-04T15:52:55+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-partners-with-gland-pharma-to-market-8-andas-in-us-271016-5649549/ 2018-07-04T15:52:58+00:00 https://www.pharmaceutical-business-review.com/news/teva-ibm-to-develop-cognitive-technologies-for-drug-repurposing-271016-5649494/ 2018-07-04T15:52:58+00:00 https://www.pharmaceutical-business-review.com/news/a14b7phoenix_data_systems_appoints_director_of_product_developm/ 2018-07-04T15:52:58+00:00 https://www.pharmaceutical-business-review.com/news/gsk-partners-with-fimbrion-to-develop-uti-drug-261016-5648604/ 2018-07-04T15:52:59+00:00 https://www.pharmaceutical-business-review.com/news/fc4a2enlyten_medical_technologies_appoints_new_chair/ 2018-07-04T15:52:59+00:00 https://www.pharmaceutical-business-review.com/news/bf4adhealthtronics_cfo_to_le/ 2018-07-04T15:52:59+00:00 https://www.pharmaceutical-business-review.com/news/03489carestream_health_appoints_chief_corporate_development_officer/ 2018-07-04T15:52:59+00:00 https://www.pharmaceutical-business-review.com/news/2f482btg_to_acquire_proth/ 2018-07-04T15:52:59+00:00 https://www.pharmaceutical-business-review.com/news/for-betrixaban-for-extended-duration-prophylaxis-of-venous-thromboembolism-in-acute-medically-ill-patients-5648486/ 2018-07-04T15:53:02+00:00 https://www.pharmaceutical-business-review.com/news/anti-her3-monoclonal-antibody-patritumab-selected-for-i-spy-2-trial-in-breast-cancer-5648462/ 2018-07-04T15:53:02+00:00 https://www.pharmaceutical-business-review.com/news/lexicon-reports-positive-results-in-phase-2-dose-ranging-study-for-sotagliflozin-in-type-1-diabetes-5648446/ 2018-07-04T15:53:02+00:00 https://www.pharmaceutical-business-review.com/news/2e492bayer_healthcare_reports_positive_fiveyear_data_from_multiple_sclerosis_/ 2018-07-04T15:53:03+00:00 https://www.pharmaceutical-business-review.com/news/22488acorda_presents_additional_data_from_second_phase_iii_multiple_sclerosis_/ 2018-07-04T15:53:03+00:00 https://www.pharmaceutical-business-review.com/news/7f4abopexa_reports_topline_data_from_phase_iib_multiple_sclerosis_/ 2018-07-04T15:53:03+00:00 https://www.pharmaceutical-business-review.com/news/8d49ccell_therapeutics_receives_fda_nod_for_submission_of_lymphoma_drug/ 2018-07-04T15:53:03+00:00 https://www.pharmaceutical-business-review.com/news/5a489calypso_medical_and_siemens_healthcare_sign_product_collaboration_agre/ 2018-07-04T15:53:04+00:00 https://www.pharmaceutical-business-review.com/news/debiopharm-reaches-key-development-milestones-for-staphylococcus-selective-antibiotic-debio-1450-5648427/ 2018-07-04T15:53:05+00:00 https://www.pharmaceutical-business-review.com/news/astrazenecas-lynparza-shows-significant-pfs-benefit-in-ovarian-cancer-patients-261016-5648086/ 2018-07-04T15:53:05+00:00 https://www.pharmaceutical-business-review.com/news/global-blood-therapeutics-to-start-phase-3-study-for-gbt440-in-sickle-cell-disease-251016-5647273/ 2018-07-04T15:53:05+00:00 https://www.pharmaceutical-business-review.com/news/88489basileas_eczema_drug_wins_marketing_approval_in_denm/ 2018-07-04T15:53:07+00:00 https://www.pharmaceutical-business-review.com/news/454bdcalypso_medical_launches_prostate_cancer_/ 2018-07-04T15:53:07+00:00 https://www.pharmaceutical-business-review.com/news/404abtrius_initiates_dosing_in_phase_ii_study_of_oral_antibacterial/ 2018-07-04T15:53:07+00:00 https://www.pharmaceutical-business-review.com/news/284a2alcon_to_expand_manufacturing_facility_in_west_vir/ 2018-07-04T15:53:08+00:00 https://www.pharmaceutical-business-review.com/news/1a481imclone_announces_launch_of_colorectal_cancer_drug_in_/ 2018-07-04T15:53:08+00:00 https://www.pharmaceutical-business-review.com/uncategorized/oasmia-enters-into-collaboration-deal-for-novel-cancer-project-5647198/ 2018-07-04T15:53:08+00:00 https://www.pharmaceutical-business-review.com/news/la-jolla-receives-positive-opinion-from-european-orphan-committee-for-ljpc-401-in-scd-251016-5647180/ 2018-07-04T15:53:09+00:00 https://www.pharmaceutical-business-review.com/news/vanda-settles-fanapt-patent-litigation-with-taro-5647149/ 2018-07-04T15:53:09+00:00 https://www.pharmaceutical-business-review.com/news/be4bcnovavax_completes_enrollment_in_phase_iia_influenza_vaccine_/ 2018-07-04T15:53:11+00:00 https://www.pharmaceutical-business-review.com/news/574b6enobias_hypophosphatasia_drug_granted_orphan_drug_design/ 2018-07-04T15:53:11+00:00 https://www.pharmaceutical-business-review.com/news/9f488ge_healthcare_wins_fda_approval_for_new_tumor_imaging_/ 2018-07-04T15:53:11+00:00 https://www.pharmaceutical-business-review.com/news/0748fcangene_files_european_marketing_application_for_hepagam_b_sol/ 2018-07-04T15:53:12+00:00 https://www.pharmaceutical-business-review.com/news/bd49eendologix_names_new_vice_president_of_qu/ 2018-07-04T15:53:12+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithkline-seeks-us-approval-for-shingles-vaccine-shingrix-251016-5646816/ 2018-07-04T15:53:13+00:00 https://www.pharmaceutical-business-review.com/news/mercks-keytruda-meets-primary-endpoint-in-urothelial-cancer-study-241016-5645381/ 2018-07-04T15:53:13+00:00 https://www.pharmaceutical-business-review.com/news/janssen-completes-two-studies-confirming-positive-efficacy-of-xarelto-rivaroxaban-in-treating-blood-clots-5645763/ 2018-07-04T15:53:13+00:00 https://www.pharmaceutical-business-review.com/news/maruishi-recruits-patient-in-japan-for-phase-iii-pivotal-clinical-trial-for-acute-respiratory-distress-syndrome-treatment-5645774/ 2018-07-04T15:53:15+00:00 https://www.pharmaceutical-business-review.com/news/9748amethylgene_exercises_royalty_right_in_cancer_drug_collaboration_with_ce/ 2018-07-04T15:53:15+00:00 https://www.pharmaceutical-business-review.com/news/2a4a3inhibox_and_nfcr_launch_new_computational_drug_screening/ 2018-07-04T15:53:15+00:00 https://www.pharmaceutical-business-review.com/news/braeburn-camurus-expand-license-agreement-to-include-new-product-for-pain-and-nausea-5645780/ 2018-07-04T15:53:16+00:00 https://www.pharmaceutical-business-review.com/news/potential-bladder-cancer-drug-opdivos-sbla-accepted-by-fda-251016-5647090/ 2018-07-04T15:53:16+00:00 https://www.pharmaceutical-business-review.com/news/1b49acardiac_dimensions_announces_key_management_chan/ 2018-07-04T15:53:16+00:00 https://www.pharmaceutical-business-review.com/news/8748dst_josephs_hospital_and_innexus_biotechnology_announce_partne/ 2018-07-04T15:53:16+00:00 https://www.pharmaceutical-business-review.com/news/4b48bscientx_launches_tribeca_cage_s/ 2018-07-04T15:53:16+00:00 https://www.pharmaceutical-business-review.com/news/amgens-xgeva-matches-zoledronic-acid-in-phase-3-trial-in-multiple-myeloma-related-bone-complications-211016-5039404/ 2018-07-04T15:53:20+00:00 https://www.pharmaceutical-business-review.com/news/sanifit-starts-first-clinical-trial-of-snf472-in-patients-with-calciphylaxis-211016-5039360/ 2018-07-04T15:53:20+00:00 https://www.pharmaceutical-business-review.com/news/theravance-and-mylans-copd-treatment-shows-benefits-in-phase-3-trials-211016-5039060/ 2018-07-04T15:53:20+00:00 https://www.pharmaceutical-business-review.com/news/94488accuray_and_morphormics_partner_in_prostate_cancer_trea/ 2018-07-04T15:53:20+00:00 https://www.pharmaceutical-business-review.com/news/6b486syneron_receives_ce_mark_for_matrix_rf_applica/ 2018-07-04T15:53:20+00:00 https://www.pharmaceutical-business-review.com/news/4e4a8lemaitre_vascular_names_new_dir/ 2018-07-04T15:53:20+00:00 https://www.pharmaceutical-business-review.com/news/f34a7vitrolifes_cfo_to_r/ 2018-07-04T15:53:20+00:00 https://www.pharmaceutical-business-review.com/news/5a482sucampo_reports_positive_results_from_phase_iib_constipation_/ 2018-07-04T15:53:21+00:00 https://www.pharmaceutical-business-review.com/news/nbe-therapeutics-sotio-partner-to-develop-next-generation-antibody-drug-conjugates-211016-5038929/ 2018-07-04T15:53:24+00:00 https://www.pharmaceutical-business-review.com/news/redx-pharma-identifies-drug-development-candidate-for-leukaemia-program-201016-5038066/ 2018-07-04T15:53:24+00:00 https://www.pharmaceutical-business-review.com/news/mercks-letermovir-succeeds-in-preventing-cmv-infection-in-phase-3-study-201016-5037908/ 2018-07-04T15:53:25+00:00 https://www.pharmaceutical-business-review.com/news/e248bteva_reports_encouraging_data_from_multiple_sclerosis_/ 2018-07-04T15:53:27+00:00 https://www.pharmaceutical-business-review.com/news/394bfincyte_reports_positive_results_from_two_phase_iia_psoriasis_st/ 2018-07-04T15:53:27+00:00 https://www.pharmaceutical-business-review.com/news/83490aradigm_names_ne/ 2018-07-04T15:53:27+00:00 https://www.pharmaceutical-business-review.com/news/da49abiolase_wins_two_new_us_patents_for_dental_technol/ 2018-07-04T15:53:27+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-lillys-lartruvo-in-combination-with-doxorubicin-for-soft-tissue-sarcoma-201016-5037830/ 2018-07-04T15:53:28+00:00 https://www.pharmaceutical-business-review.com/news/phase-2-study-of-pegylated-interferon-lambda-in-hepatitis-d-virus-hdv-infection-5037511/ 2018-07-04T15:53:28+00:00 https://www.pharmaceutical-business-review.com/news/8d486kemin_industries_names_new_president_of_kemin_p/ 2018-07-04T15:53:28+00:00 https://www.pharmaceutical-business-review.com/news/sobi003-receives-ec-orphan-designation-to-treat-mucopolysaccharidosis-type-iiia-201016-5037500/ 2018-07-04T15:53:29+00:00 https://www.pharmaceutical-business-review.com/news/sun-pharma-icgeb-partner-to-develop-dengue-vaccine-201016-5037253/ 2018-07-04T15:53:33+00:00 https://www.pharmaceutical-business-review.com/news/domain-therapeutics-creates-new-company-to-stop-parkinsons-disease-progression-191016-5036548/ 2018-07-04T15:53:33+00:00 https://www.pharmaceutical-business-review.com/news/shires-onivyde-approved-in-europe-for-pancreatic-cancer-5036158/ 2018-07-04T15:53:33+00:00 https://www.pharmaceutical-business-review.com/news/c94b9abbotts_humira_demonstrates_efficacy_in_psoriasis_/ 2018-07-04T15:53:33+00:00 https://www.pharmaceutical-business-review.com/news/b2495alseres_wins_orphan_drug_designation_for_spinal_cord_injury/ 2018-07-04T15:53:33+00:00 https://www.pharmaceutical-business-review.com/news/00493dr_reddys_launches_us_specialty_business_promius_p/ 2018-07-04T15:53:33+00:00 https://www.pharmaceutical-business-review.com/news/d74a4flamel_receives_500000_payment_from_wyeth_pharmaceut/ 2018-07-04T15:53:34+00:00 https://www.pharmaceutical-business-review.com/news/d64bfinterleukin_and_geisinger_collaborate_in_obesity_res/ 2018-07-04T15:53:34+00:00 https://www.pharmaceutical-business-review.com/news/lls-launches-collaborative-clinical-trial-for-acute-myeloid-leukemia-191016-5036142/ 2018-07-04T15:53:36+00:00 https://www.pharmaceutical-business-review.com/news/clinigen-expands-operations-into-japan-5036129/ 2018-07-04T15:53:36+00:00 https://www.pharmaceutical-business-review.com/uncategorized/fda-approves-genentechs-tecentriq-for-metastatic-non-small-cell-lung-cancer-191016-5036080/ 2018-07-04T15:53:36+00:00 https://www.pharmaceutical-business-review.com/news/a4496isoaid_wins_threeyear_brachytherapy_contract_from_ame/ 2018-07-04T15:53:37+00:00 https://www.pharmaceutical-business-review.com/news/5a496merck_serono_initiates_phase_iii_multiple_sclerosis_/ 2018-07-04T15:53:37+00:00 https://www.pharmaceutical-business-review.com/news/d64aeamt_licenses_amgens_gdnf_gene_for_development_of_parkinsons/ 2018-07-04T15:53:37+00:00 https://www.pharmaceutical-business-review.com/news/974a5neose_signs_asset_purchase_agreements_with_novo_nordisk_and_bioge/ 2018-07-04T15:53:37+00:00 https://www.pharmaceutical-business-review.com/news/6e497lifecycle_pharmas_cmo_to_r/ 2018-07-04T15:53:38+00:00 https://www.pharmaceutical-business-review.com/news/chmp-recommends-marketing-approval-for-ferrings-rekovell-for-use-in-controlled-ovarian-stimulation-181016-5035043/ 2018-07-04T15:53:39+00:00 https://www.pharmaceutical-business-review.com/news/antegrin-and-cascadia-merge-to-form-indalo-therapeutics-181016-5034962/ 2018-07-04T15:53:39+00:00 https://www.pharmaceutical-business-review.com/news/fdas-ode-i-denies-ptc-therapeutics-dmd-drug-appeal-181016-5034854/ 2018-07-04T15:53:40+00:00 https://www.pharmaceutical-business-review.com/news/41481wyeth_reports_positive_results_from_psoriasis_/ 2018-07-04T15:53:41+00:00 https://www.pharmaceutical-business-review.com/news/c149beli_lilly_names_new_cha/ 2018-07-04T15:53:41+00:00 https://www.pharmaceutical-business-review.com/news/094abcentocors_ustekinumab_found_to_be_effective_in_phase_iii_psoriasis_/ 2018-07-04T15:53:41+00:00 https://www.pharmaceutical-business-review.com/news/4548cteva_announces_positive_data_from_multiple_sclerosis_extension_/ 2018-07-04T15:53:42+00:00 https://www.pharmaceutical-business-review.com/news/134a5avigen_completes_phase_iib_spasticity_/ 2018-07-04T15:53:42+00:00 https://www.pharmaceutical-business-review.com/news/sofinnova-closes-latest-venture-capital-fund-at-650m-181016-5034807/ 2018-07-04T15:53:43+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-plans-to-launch-remicade-biosimilar-in-november-5034798/ 2018-07-04T15:53:43+00:00 https://www.pharmaceutical-business-review.com/news/fda-places-clinical-hold-on-regeneron-and-tevas-pain-drug-trial-181016-5034562/ 2018-07-04T15:53:43+00:00 https://www.pharmaceutical-business-review.com/news/ef4b5roche_receives_fda_complete_response_letter_for_arthritis/ 2018-07-04T15:53:46+00:00 https://www.pharmaceutical-business-review.com/news/57482maxygen_and_astellas_pharma_partner_in_autoimmune_drug_res/ 2018-07-04T15:53:46+00:00 https://www.pharmaceutical-business-review.com/news/a4480solx_wins_fda_approval_for_new_glaucoma_/ 2018-07-04T15:53:46+00:00 https://www.pharmaceutical-business-review.com/news/6149fassay_designs_introduces_new_line_of_multibead_multiplex_immunoa/ 2018-07-04T15:53:47+00:00 https://www.pharmaceutical-business-review.com/news/83494profibrix_names_ne/ 2018-07-04T15:53:47+00:00 https://www.pharmaceutical-business-review.com/uncategorized/virtus-sues-fda-for-clearing-potassium-chloride-market-of-competition-171016-5033656/ 2018-07-04T15:53:48+00:00 https://www.pharmaceutical-business-review.com/news/clementia-announces-phase-2-clinical-trial-results-of-fop-palovarotene-171016-5033572/ 2018-07-04T15:53:48+00:00 https://www.pharmaceutical-business-review.com/news/zucara-signs-licensing-agreement-with-cdrd-for-therapeutic-drug-compounds-171016-5033523/ 2018-07-04T15:53:48+00:00 https://www.pharmaceutical-business-review.com/news/454abnovadel_announces_extension_of_pdufa_review_deadline_for_insomnia/ 2018-07-04T15:53:51+00:00 https://www.pharmaceutical-business-review.com/news/cd490cellectar_names_new_board_m/ 2018-07-04T15:53:51+00:00 https://www.pharmaceutical-business-review.com/news/1b4a0perrigo_announces_dismissal_of_miconazole_patent_la/ 2018-07-04T15:53:51+00:00 https://www.pharmaceutical-business-review.com/news/cc4b8ibiopharma_selects_influenza_vaccine_as_first_drug_cand/ 2018-07-04T15:53:51+00:00 https://www.pharmaceutical-business-review.com/news/a2491kemin_pharma_establishes_new_offices_in_/ 2018-07-04T15:53:52+00:00 https://www.pharmaceutical-business-review.com/news/tetraphase-offers-doses-first-patient-in-ignite4-phase-3-clinical-trial-of-eravacycline-in-ciai-171016-5033323/ 2018-07-04T15:53:53+00:00 https://www.pharmaceutical-business-review.com/uncategorized/chmp-issues-positive-opinion-for-bms-opdivo-in-hodgkin-lymphoma-171016-5033090/ 2018-07-04T15:53:53+00:00 https://www.pharmaceutical-business-review.com/news/uk-mhra-approves-continued-enrollment-in-biomarins-phase-12-study-of-bmn-270-141016-5032243/ 2018-07-04T15:53:53+00:00 https://www.pharmaceutical-business-review.com/news/af491oni_biopharma_to_launch_oral_probiotic_pr/ 2018-07-04T15:53:54+00:00 https://www.pharmaceutical-business-review.com/news/584a2medartis_names_new_president_of_us_opera/ 2018-07-04T15:53:55+00:00 https://www.pharmaceutical-business-review.com/news/2a4a0roxane_laboratories_launches_protriptyline_hcl_tablets/ 2018-07-04T15:53:55+00:00 https://www.pharmaceutical-business-review.com/news/104a1mannatech_to_begin_operations_in_sing/ 2018-07-04T15:53:55+00:00 https://www.pharmaceutical-business-review.com/news/fe488us_oncology_names_new_executive_vice_president_an/ 2018-07-04T15:53:55+00:00 https://www.pharmaceutical-business-review.com/news/trevi-therapeutics-registers-positive-phase-2-trial-results-in-prurigo-nodularis-141016-5032196/ 2018-07-04T15:53:56+00:00 https://www.pharmaceutical-business-review.com/news/transthera-raises-10m-in-round-a-financing-141016-5032171/ 2018-07-04T15:53:56+00:00 https://www.pharmaceutical-business-review.com/news/vbl-therapeutics-plans-to-build-new-manufacturing-facility-in-israel-141016-5031795/ 2018-07-04T15:53:57+00:00 https://www.pharmaceutical-business-review.com/news/true-norths-tnt009-gets-fda-orphan-drug-status-to-treat-autoimmune-hemolytic-anemia-141016-5031701/ 2018-07-04T15:54:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-qidp-and-fast-track-designations-to-viamets-vt-1161-to-treat-rvcc-131016-5030764/ 2018-07-04T15:54:00+00:00 https://www.pharmaceutical-business-review.com/news/amag-achieves-key-milestones-in-makena-feraheme-development-programs-131016-5030453/ 2018-07-04T15:54:01+00:00 https://www.pharmaceutical-business-review.com/news/prometics-pbi-4050-significantly-reduces-liver-fibrosis-in-alstrm-syndrome-patients-131016-5030438/ 2018-07-04T15:54:03+00:00 https://www.pharmaceutical-business-review.com/news/regenicin-secures-pre-ind-meeting-with-fda-for-novaderm-131016-5030338/ 2018-07-04T15:54:04+00:00 https://www.pharmaceutical-business-review.com/news/biocad-biotechnology-begins-phase-2-clinical-trials-of-psoriasis-drug-131016-5030274/ 2018-07-04T15:54:04+00:00 https://www.pharmaceutical-business-review.com/news/81490enigma_diagnostics_awarded_gbp18_million_by_uk_gover/ 2018-07-04T15:54:05+00:00 https://www.pharmaceutical-business-review.com/news/704bamartek_signs_solesource_supply_agreement_with/ 2018-07-04T15:54:05+00:00 https://www.pharmaceutical-business-review.com/news/8e48dincyte_names_new_chief_commercial_of/ 2018-07-04T15:54:05+00:00 https://www.pharmaceutical-business-review.com/news/9e49ckjaya_wins_fda_clearance_for_distribution_and_visualization_sol/ 2018-07-04T15:54:05+00:00 https://www.pharmaceutical-business-review.com/news/bb48denteromedicss_cmo_re/ 2018-07-04T15:54:06+00:00 https://www.pharmaceutical-business-review.com/news/064bdnanosphere_names_new_dir/ 2018-07-04T15:54:09+00:00 https://www.pharmaceutical-business-review.com/news/544aabig_pharma_parallel_importers_welcome_eu_ruling_over_parallel_/ 2018-07-04T15:54:09+00:00 https://www.pharmaceutical-business-review.com/news/ed498sanofi_pasteur_sponsors_phase_ii_melanoma_/ 2018-07-04T15:54:09+00:00 https://www.pharmaceutical-business-review.com/news/9e4bamemory_pharmaceuticals_to_downsize_work/ 2018-07-04T15:54:09+00:00 https://www.pharmaceutical-business-review.com/news/034a1bilcare_gcs_expands_us_fac/ 2018-07-04T15:54:10+00:00 https://www.pharmaceutical-business-review.com/news/rxi-pharmaceuticals-signs-option-deal-to-buy-mirimmune-131016-5030243/ 2018-07-04T15:54:12+00:00 https://www.pharmaceutical-business-review.com/uncategorized/ibm-makes-watson-technology-available-to-us-employees-fighting-cancer-121016-5029486/ 2018-07-04T15:54:12+00:00 https://www.pharmaceutical-business-review.com/news/nymox-reports-results-forphase-3-long-term-fexapotide-repeat-injection-bph-trial-121016-5029400/ 2018-07-04T15:54:12+00:00 https://www.pharmaceutical-business-review.com/news/cf488amerigroup_to_start_operations_in_n/ 2018-07-04T15:54:14+00:00 https://www.pharmaceutical-business-review.com/news/824aegore_wins_approval_for_expanded_indication_of_gore_viabahn_stent/ 2018-07-04T15:54:15+00:00 https://www.pharmaceutical-business-review.com/news/7b483crucell_signs_licensing_agreement_with_talecris_biotherape/ 2018-07-04T15:54:15+00:00 https://www.pharmaceutical-business-review.com/news/e548dnovocell_wins_new_patents_for_stem_cell_technol/ 2018-07-04T15:54:15+00:00 https://www.pharmaceutical-business-review.com/news/5e49eomeros_forms_partnership_for_treatment_of_movement_diso/ 2018-07-04T15:54:15+00:00 https://www.pharmaceutical-business-review.com/news/pfizers-sutent-shows-positive-phase-3-results-in-renal-cell-carcinoma-121016-5029364/ 2018-07-04T15:54:17+00:00 https://www.pharmaceutical-business-review.com/news/tfs-acquires-dermatology-specialist-sciderm-121016-5029355/ 2018-07-04T15:54:18+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-grants-priority-review-to-genentechs-lucentis-license-application-121016-5029337/ 2018-07-04T15:54:18+00:00 https://www.pharmaceutical-business-review.com/news/524bdaurobindo_pharma_obtains_tentative_approval_for_hiv/ 2018-07-04T15:54:19+00:00 https://www.pharmaceutical-business-review.com/news/7448fvertex_pharmaceuticals_to_offer_7_million_shares_in_public_off/ 2018-07-04T15:54:19+00:00 https://www.pharmaceutical-business-review.com/news/4e488vivendys_morquio_drug_receives_orphan_drug_design/ 2018-07-04T15:54:19+00:00 https://www.pharmaceutical-business-review.com/news/9c4bcovation_acquires_rights_to_prestwicks_huntingtons/ 2018-07-04T15:54:19+00:00 https://www.pharmaceutical-business-review.com/news/124a5tethys_bioscience_acquires_lipomics_technol/ 2018-07-04T15:54:20+00:00 https://www.pharmaceutical-business-review.com/news/transgene-partners-with-merck-pfizer-for-head-and-neck-cancer-trial-2-5029127/ 2018-07-04T15:54:21+00:00 https://www.pharmaceutical-business-review.com/news/engenelc-enters-into-research-collaboration-with-takeda-101016-5027753/ 2018-07-04T15:54:22+00:00 https://www.pharmaceutical-business-review.com/news/aprea-enrolls-first-patients-in-phase-ii-clinical-study-of-serous-ovarian-cancer-drug-1010116-5027919/ 2018-07-04T15:54:22+00:00 https://www.pharmaceutical-business-review.com/news/99483biocurex_wins_australian_patent_on_therapeutic_applications_for_recaf_m/ 2018-07-04T15:54:23+00:00 https://www.pharmaceutical-business-review.com/news/b148faethlon_medical_reports_encouraging_results_from_hepatitis_/ 2018-07-04T15:54:23+00:00 https://www.pharmaceutical-business-review.com/news/a74b4s_bio_initiates_us_phase_i_trials_of_cancer/ 2018-07-04T15:54:23+00:00 https://www.pharmaceutical-business-review.com/news/754bdcovidien_introduces_tussicaps_er_capsules_/ 2018-07-04T15:54:24+00:00 https://www.pharmaceutical-business-review.com/news/scancell-intends-to-develop-scib2-for-treatment-of-lung-cancer-101016-5028276/ 2018-07-04T15:54:25+00:00 https://www.pharmaceutical-business-review.com/uncategorized/nexus-biopharma-signs-deal-with-transchem-for-kinase-inhibition-technology-071016-5027374/ 2018-07-04T15:54:26+00:00 https://www.pharmaceutical-business-review.com/uncategorized/astrazeneca-to-sell-ex-us-rights-to-rhinocort-aqua-nasal-spray-to-jj-affiliate-081016-5027407/ 2018-07-04T15:54:26+00:00 https://www.pharmaceutical-business-review.com/news/6348aaurillion_names_new_vice_president_of_sales_and_mark/ 2018-07-04T15:54:28+00:00 https://www.pharmaceutical-business-review.com/news/76481china_biologic_wins_sfda_approval_for_hemophilia_/ 2018-07-04T15:54:28+00:00 https://www.pharmaceutical-business-review.com/news/5f49amemory_and_roche_expand_phase_ii_schizophrenia_drug_development_pr/ 2018-07-04T15:54:28+00:00 https://www.pharmaceutical-business-review.com/news/8c4a7depomed_initiates_phase_iii_menopausal_hot_flashes_pr/ 2018-07-04T15:54:28+00:00 https://www.pharmaceutical-business-review.com/news/d04b7biovail_acquires_prestwick_pharmaceut/ 2018-07-04T15:54:29+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-priority-review-for-genmabs-daratumumab-in-relapsed-multiple-myeloma-081016-5027408/ 2018-07-04T15:54:30+00:00 https://www.pharmaceutical-business-review.com/news/exelixis-announces-phase-1-trial-results-for-cabozantinib-in-combination-with-nivolumab-in-advanced-genitourinary-tumors-5027409/ 2018-07-04T15:54:30+00:00 https://www.pharmaceutical-business-review.com/news/lundbeck-wins-fda-approval-for-intravenous-carnexiv-for-temporary-treatment-of-seizures-081016-5027410/ 2018-07-04T15:54:31+00:00 https://www.pharmaceutical-business-review.com/news/28481auxilium_initiates_dosing_for_phase_iib_peyronies_/ 2018-07-04T15:54:35+00:00 https://www.pharmaceutical-business-review.com/news/1a4a2amarin_names_new_senior_vice_president_and_head_of_develo/ 2018-07-04T15:54:35+00:00 https://www.pharmaceutical-business-review.com/news/92480mtm_laboratories_introduces_cintec_cytology_kit_in_e/ 2018-07-04T15:54:36+00:00 https://www.pharmaceutical-business-review.com/news/664besignum_biosciences_signs_investment_and_licensing_agreements_with_/ 2018-07-04T15:54:36+00:00 https://www.pharmaceutical-business-review.com/news/6a48fsurmodics_announces_termination_of_research_collaboration_with_/ 2018-07-04T15:54:36+00:00 https://www.pharmaceutical-business-review.com/uncategorized/merck-opens-biopharmaceutical-support-center-in-korea-071016-5027167/ 2018-07-04T15:54:37+00:00 https://www.pharmaceutical-business-review.com/news/flamel-technologies-signs-deal-with-fda-on-protocol-for-phase-iii-trial-of-ft218-071016-5027092/ 2018-07-04T15:54:38+00:00 https://www.pharmaceutical-business-review.com/uncategorized/synthetic-biologics-wins-research-contract-from-us-cdc-071016-5027075/ 2018-07-04T15:54:38+00:00 https://www.pharmaceutical-business-review.com/news/6249aeleme_medical_granted_ce_mark_for_smoothshapes_s/ 2018-07-04T15:54:40+00:00 https://www.pharmaceutical-business-review.com/news/f14a1nephros_names_new_president_an/ 2018-07-04T15:54:40+00:00 https://www.pharmaceutical-business-review.com/news/444b9ranaz_raises_18_million_in_fina/ 2018-07-04T15:54:40+00:00 https://www.pharmaceutical-business-review.com/news/ab48cbioimagene_names_ne/ 2018-07-04T15:54:40+00:00 https://www.pharmaceutical-business-review.com/news/cf489three_rivers_pharmaceuticals_signs_licensing_agreement_with_/ 2018-07-04T15:54:41+00:00 https://www.pharmaceutical-business-review.com/news/metabrain-research-and-medicxi-establish-kymo-therapeutics-071016-5027036/ 2018-07-04T15:54:42+00:00 https://www.pharmaceutical-business-review.com/news/kite-pharma-starts-phase-1b2-combination-study-for-kte-c19-and-atezolizumab-in-refractory-dlbcl-5027010/ 2018-07-04T15:54:42+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-orexos-low-dose-zubsolv-to-treat-opioid-dependence-071016-5026797/ 2018-07-04T15:54:42+00:00 https://www.pharmaceutical-business-review.com/news/ef49cmyriad_genetics_reports_encouraging_results_from_phase_i_hiv_/ 2018-07-04T15:54:44+00:00 https://www.pharmaceutical-business-review.com/news/5f482daiichi_sankyo_submits_snda_for_hypertension/ 2018-07-04T15:54:45+00:00 https://www.pharmaceutical-business-review.com/news/5c497chemgenex_raises_a129_million_in_fina/ 2018-07-04T15:54:45+00:00 https://www.pharmaceutical-business-review.com/news/e94bacaliber_and_dsm_biomedical_to_develop_new_drug_delivery_balloon_cathe/ 2018-07-04T15:54:45+00:00 https://www.pharmaceutical-business-review.com/news/b94bcgenstruct_names_new_vice_president_of_sa/ 2018-07-04T15:54:45+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-scraps-rnai-drug-development-over-safety-concerns-061016-5025839/ 2018-07-04T15:54:45+00:00 https://www.pharmaceutical-business-review.com/uncategorized/insmed-signs-worldwide-license-deal-with-astrazeneca-for-oral-dpp1-inhibitor-061016-5025667/ 2018-07-04T15:54:45+00:00 https://www.pharmaceutical-business-review.com/news/codexis-completes-final-phase-in-transfer-of-codeevolver-technology-to-merck-061016-5025649/ 2018-07-04T15:54:45+00:00 https://www.pharmaceutical-business-review.com/news/4a4a9valeant_pharmaceuticals_to_acquire_coria_laborat/ 2018-07-04T15:54:48+00:00 https://www.pharmaceutical-business-review.com/news/33490perrigo_acquires_jb_laborat/ 2018-07-04T15:54:48+00:00 https://www.pharmaceutical-business-review.com/news/cb4a0novavax_initiates_vaccination_in_phase_ii_influenza_vaccine_pr/ 2018-07-04T15:54:48+00:00 https://www.pharmaceutical-business-review.com/news/354bcsciele_pharma_completes_phase_iii_drooling_program_in_pediatric_pat/ 2018-07-04T15:54:49+00:00 https://www.pharmaceutical-business-review.com/news/a549bgetinge_to_acquire_data/ 2018-07-04T15:54:49+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-velicepts-ind-to-start-phase-i-study-for-solabegron-061016-5025631/ 2018-07-04T15:54:49+00:00 https://www.pharmaceutical-business-review.com/news/intas-to-buy-actavis-uk-and-ireland-business-form-teva-061016-5025389/ 2018-07-04T15:54:49+00:00 https://www.pharmaceutical-business-review.com/news/astrazenecas-brilinta-heart-drug-fails-in-peripheral-artery-disease-trial-051016-5024455/ 2018-07-04T15:54:49+00:00 https://www.pharmaceutical-business-review.com/news/theravance-doses-first-patient-in-phase-1b-trial-of-td-1473-in-moderate-to-severe-ulcerative-colitis-051016-5024334/ 2018-07-04T15:54:52+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-enters-into-immuno-oncology-research-collaboration-with-agonox-051016-5024241/ 2018-07-04T15:54:52+00:00 https://www.pharmaceutical-business-review.com/news/7e480visionsciences_names_new_executive_vicepresident_an/ 2018-07-04T15:54:52+00:00 https://www.pharmaceutical-business-review.com/news/8e4acveran_medical_names_new_board_m/ 2018-07-04T15:54:52+00:00 https://www.pharmaceutical-business-review.com/news/sarepta-and-summit-partner-to-develop-novel-therapies-for-duchenne-muscular-dystrophy-051016-5024214/ 2018-07-04T15:54:53+00:00 https://www.pharmaceutical-business-review.com/news/dc490mannkind_to_provide_inhaled_insulin_to_pfizers_exubera_pat/ 2018-07-04T15:54:53+00:00 https://www.pharmaceutical-business-review.com/news/e94baepix_achieves_new_milestone_in_its_collaboration_with/ 2018-07-04T15:54:53+00:00 https://www.pharmaceutical-business-review.com/news/054adgeron_granted_new_us_patent_for_cardiomyo/ 2018-07-04T15:54:53+00:00 https://www.pharmaceutical-business-review.com/news/roches-actemraroactemra-gets-fda-breakthrough-therapy-status-for-giant-cell-arteritis-051016-5024051/ 2018-07-04T15:54:56+00:00 https://www.pharmaceutical-business-review.com/news/japanese-cell-biologist-yoshinori-ohsumi-wins-nobel-prize-in-medicine-041016-5023093/ 2018-07-04T15:54:56+00:00 https://www.pharmaceutical-business-review.com/news/54492fda_warns_on_ranbaxy_indianmade_drugs_blocks_import_of_30_generic_/ 2018-07-04T15:54:56+00:00 https://www.pharmaceutical-business-review.com/news/recursion-pharmaceuticals-raises-129m-to-apply-ai-to-drug-discovery-041016-5022942/ 2018-07-04T15:54:57+00:00 https://www.pharmaceutical-business-review.com/news/cd488merck_presents_positive_data_from_phase_iib_osteoporosis_/ 2018-07-04T15:54:57+00:00 https://www.pharmaceutical-business-review.com/news/9c494cytokinetics_announces_restructuring_ends_cancer_res/ 2018-07-04T15:54:57+00:00 https://www.pharmaceutical-business-review.com/news/50496mediware_licenses_blood_donor_management_software_to/ 2018-07-04T15:54:57+00:00 https://www.pharmaceutical-business-review.com/news/7d4b7arkal_medical_raises_175_million_in_series_b_fina/ 2018-07-04T15:54:57+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-approves-transfer-of-marketing-authorisation-for-alprolix-to-sobi-041016-5022909/ 2018-07-04T16:01:20+00:00 https://www.pharmaceutical-business-review.com/uncategorized/allergan-signs-15bn-licensing-deal-for-astrazenecas-inflammatory-diseases-drug-041016-5022509/ 2018-07-04T16:01:21+00:00 https://www.pharmaceutical-business-review.com/news/nice-recommends-new-drug-osimertinib-for-hundreds-of-people-with-lung-cancer-5680944/ 2018-07-04T16:01:22+00:00 https://www.pharmaceutical-business-review.com/news/novartis-cosentyx-demonstrates-long-lasting-skin-clearance-in-plaque-psoriasis-031016-5021565/ 2018-07-04T16:01:22+00:00 https://www.pharmaceutical-business-review.com/news/janssens-guselkumab-beats-humira-in-psoriasis-study-031016-5021379/ 2018-07-04T16:01:23+00:00 https://www.pharmaceutical-business-review.com/news/regenerons-eylea-combination-therapy-fails-phase-2-study-in-wet-amd-031016-5021352/ 2018-07-04T16:01:24+00:00 https://www.pharmaceutical-business-review.com/news/depomed-gets-favorable-patent-ruling-in-us-for-nucynta-andas-031016-5021321/ 2018-07-04T16:01:24+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-breakthrough-therapy-status-to-abbvies-investigational-hcv-regimen-031016-5021006/ 2018-07-04T16:01:25+00:00 https://www.pharmaceutical-business-review.com/news/catabasis-sarepta-partner-to-explore-combination-drug-for-duchenne-muscular-dystrophy-300916-5020364/ 2018-07-04T16:01:26+00:00 https://www.pharmaceutical-business-review.com/news/novo-nordisk-plans-to-cut-1000-jobs-amid-increasing-competition-300916-5020346/ 2018-07-04T16:01:26+00:00 https://www.pharmaceutical-business-review.com/news/hanmi-pharmaceutical-signs-license-deal-with-genentech-for-novel-oral-raf-inhibitor-300916-5020052/ 2018-07-04T16:01:26+00:00 https://www.pharmaceutical-business-review.com/news/c2490orexo_acquires_biolipo/ 2018-07-04T16:01:27+00:00 https://www.pharmaceutical-business-review.com/news/bayer-delsitech-partner-to-develop-new-drug-delivery-technology-for-ophthalmology-200916-5020041/ 2018-07-04T16:01:28+00:00 https://www.pharmaceutical-business-review.com/news/amgen-arrowhead-to-develop-gene-therapies-for-cardiovascular-disease-300916-5019931/ 2018-07-04T16:01:28+00:00 https://www.pharmaceutical-business-review.com/uncategorized/intra-cellular-therapies-schizophrenia-drug-fails-in-phase-3-trial-290916-5019116/ 2018-07-04T16:01:29+00:00 https://www.pharmaceutical-business-review.com/news/oncodesign-to-buy-gsks-french-research-center-290916-5019026/ 2018-07-04T16:01:30+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-viratherapeutics-partner-to-jointly-develop-oncolytic-virus-therapy-platform-290916-5018996/ 2018-07-04T16:01:30+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-closes-medivation-acquisition-290916-5018953/ 2018-07-04T16:01:30+00:00 https://www.pharmaceutical-business-review.com/news/novartis-and-amgens-erenumab-succeeds-in-phase-3-study-in-migraine-prevention-290916-5018715/ 2018-07-04T16:01:32+00:00 https://www.pharmaceutical-business-review.com/uncategorized/fda-grants-rare-pediatric-disease-designation-to-summit-therapeutics-dmd-drug-280916-5017927/ 2018-07-04T16:01:32+00:00 https://www.pharmaceutical-business-review.com/news/redx-pharma-discovers-breakthrough-antibiotic-compounds-280916-5017844/ 2018-07-04T16:01:32+00:00 https://www.pharmaceutical-business-review.com/news/pronai-secures-global-rights-to-chk1-inhibitor-cancer-drug-candidate-cct245737-280916-5017831/ 2018-07-04T16:01:33+00:00 https://www.pharmaceutical-business-review.com/news/c4x-discovery-enters-into-multi-target-risk-sharing-alliance-with-evotec-280916-5017816/ 2018-07-04T16:01:34+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-to-test-opdivo-with-nektar-therapeutics-drug-in-five-tumor-types-280916-5017494/ 2018-07-04T16:01:34+00:00 https://www.pharmaceutical-business-review.com/news/154actraumacure_wins_health_canada_license_for_new_hemostatic_/ 2018-07-04T16:02:35+00:00 https://www.pharmaceutical-business-review.com/news/a4483clx_medical_to_acquire_thyrotecs_rapid_screening_d/ 2018-07-04T16:02:35+00:00 https://www.pharmaceutical-business-review.com/news/5b4aegenerex_reaches_enrollment_milestone_in_phase_iii_diabetes_/ 2018-07-04T16:02:35+00:00 https://www.pharmaceutical-business-review.com/news/f44a0aegis_awarded_new_patent_for_stable_human_growth_hormone_formula/ 2018-07-04T16:02:35+00:00 https://www.pharmaceutical-business-review.com/news/c64a4micrus_endovascular_launches_new_neuropath_guide_cat/ 2018-07-04T16:02:36+00:00 https://www.pharmaceutical-business-review.com/news/754b6innexuss_tumor_drug_found_superior_to_rituxan_in_animal_st/ 2018-07-04T16:02:37+00:00 https://www.pharmaceutical-business-review.com/news/5d493compugen_discovers_second_peptide_drug_candidate_for_cancer_trea/ 2018-07-04T16:02:37+00:00 https://www.pharmaceutical-business-review.com/news/c34affresenius_closes_licensing_agreement_for_intravenous_iron_pro/ 2018-07-04T16:02:37+00:00 https://www.pharmaceutical-business-review.com/news/2e4adformatech_awarded_patent_for_new_drug_formul/ 2018-07-04T16:02:38+00:00 https://www.pharmaceutical-business-review.com/news/92486sembiosys_to_proceed_with_phase_iii_study_of_safflowerproduced_in/ 2018-07-04T16:02:38+00:00 https://www.pharmaceutical-business-review.com/news/f14a6glaxosmithkline_and_xenoport_file_nda_for_restless_legs_syndrome/ 2018-07-04T16:02:39+00:00 https://www.pharmaceutical-business-review.com/news/a148aambrilia_biopharma_develops_onemonth_formulation_of_gose/ 2018-07-04T16:02:39+00:00 https://www.pharmaceutical-business-review.com/news/fb4basirtris_signs_licensing_agreement_with_harvard_unive/ 2018-07-04T16:02:39+00:00 https://www.pharmaceutical-business-review.com/news/864b5dr_reddys_wins_fda_approval_for_dementia/ 2018-07-04T16:02:40+00:00 https://www.pharmaceutical-business-review.com/news/b248dmylan_wins_fda_approval_for_generic_risperdal_ta/ 2018-07-04T16:02:40+00:00 https://www.pharmaceutical-business-review.com/news/c94bcregeneron_and_columbia_university_collaborate_to_discover_monoclonal_antib/ 2018-07-04T16:02:41+00:00 https://www.pharmaceutical-business-review.com/news/504bcwelldoc_and_astrazeneca_partner_to_develop_asthma_management_sol/ 2018-07-04T16:02:41+00:00 https://www.pharmaceutical-business-review.com/news/5b4a6javelin_completes_enrollment_for_second_phase_iii_study_of_pain/ 2018-07-04T16:02:42+00:00 https://www.pharmaceutical-business-review.com/news/114aecyntellect_names_new_vice_president_an/ 2018-07-04T16:02:42+00:00 https://www.pharmaceutical-business-review.com/news/06483gilead_receives_fda_complete_response_letter_for_cystic_fibrosis/ 2018-07-04T16:02:42+00:00 https://www.pharmaceutical-business-review.com/news/c74aaoramed_pharmaceuticals_launches_preclinical_trials_of_diabetes/ 2018-07-04T16:02:43+00:00 https://www.pharmaceutical-business-review.com/news/464b9barr_wins_fda_approval_for_generic_razadyne_er_cap/ 2018-07-04T16:02:44+00:00 https://www.pharmaceutical-business-review.com/news/3049fteva_wins_eu_marketing_authorization_for_neutropenia/ 2018-07-04T16:02:44+00:00 https://www.pharmaceutical-business-review.com/news/bb4a1cytochroma_names_new_vice_president_of_regulatory_af/ 2018-07-04T16:02:44+00:00 https://www.pharmaceutical-business-review.com/news/d94a7transgenomic_partners_with_key_genomics_to_develop_ovarian_cancer_/ 2018-07-04T16:02:44+00:00 https://www.pharmaceutical-business-review.com/news/ef481pharmacopeia_and_gsk_alliance_identifies_new_drug_com/ 2018-07-04T16:02:48+00:00 https://www.pharmaceutical-business-review.com/news/bf4a6merck_completes_enrollment_in_phase_iii_multiple_sclerosis_/ 2018-07-04T16:02:48+00:00 https://www.pharmaceutical-business-review.com/news/cd491enobia_pharma_reports_positive_preclinical_data_from_hypophosphatasia_/ 2018-07-04T16:02:49+00:00 https://www.pharmaceutical-business-review.com/news/c64a4bristolmyers_announces_updated_survival_data_from_phase_ii_melanoma_st/ 2018-07-04T16:02:49+00:00 https://www.pharmaceutical-business-review.com/news/454adastrazeneca_announces_topline_results_from_phase_iib_alzheimers_/ 2018-07-04T16:02:49+00:00 https://www.pharmaceutical-business-review.com/news/5048cpfizer_reports_encouraging_results_from_phase_ii_lung_cancer_/ 2018-07-04T16:02:50+00:00 https://www.pharmaceutical-business-review.com/news/554afcalando_announces_development_of_second_sirna_cancer/ 2018-07-04T16:02:51+00:00 https://www.pharmaceutical-business-review.com/news/2a48enextrials_makes_new_executive_appoint/ 2018-07-04T16:02:51+00:00 https://www.pharmaceutical-business-review.com/news/76497alma_lasers_launches_new_pixel_co2_skin_resurfacing_s/ 2018-07-04T16:02:51+00:00 https://www.pharmaceutical-business-review.com/news/f44b8nps_reports_positive_interim_data_from_phase_ii_hypoparathyroidism_/ 2018-07-04T16:02:51+00:00 https://www.pharmaceutical-business-review.com/news/bb49csinovac_initiates_hepatitis_a_vaccine_trials_in_uk/ 2018-07-04T16:02:53+00:00 https://www.pharmaceutical-business-review.com/news/f8499cardica_wins_1_million_milestone_payment_from_cook_me/ 2018-07-04T16:02:53+00:00 https://www.pharmaceutical-business-review.com/news/f548bstem_cell_obtains_health_canadas_no_objection_letter_for_brain_injury_/ 2018-07-04T16:02:53+00:00 https://www.pharmaceutical-business-review.com/news/f24b6imedica_and_misys_settle_di/ 2018-07-04T16:02:53+00:00 https://www.pharmaceutical-business-review.com/news/dc4a2volcanos_chairman_to_r/ 2018-07-04T16:02:54+00:00 https://www.pharmaceutical-business-review.com/news/42485trianim_signs_distribution_agreement_with_intersur/ 2018-07-04T16:02:55+00:00 https://www.pharmaceutical-business-review.com/news/a54a5ge_healthcare_and_varian_to_collaborate_on_new_mir_s/ 2018-07-04T16:02:55+00:00 https://www.pharmaceutical-business-review.com/news/7348bforest_laboratories_names_new_vice_president_of_investor_rela/ 2018-07-04T16:02:55+00:00 https://www.pharmaceutical-business-review.com/news/bd4a4proteologics_and_teva_extend_collabor/ 2018-07-04T16:02:56+00:00 https://www.pharmaceutical-business-review.com/news/5649cenanta_pharmaceuticals_initiates_phase_ia_study_of_oral_antib/ 2018-07-04T16:02:56+00:00 https://www.pharmaceutical-business-review.com/news/1c491amicus_therapeutics_establishes_new_facility_in_san_/ 2018-07-04T16:02:57+00:00 https://www.pharmaceutical-business-review.com/news/444a7cas_medical_names_new_vice_president_of_sales_and_mark/ 2018-07-04T16:02:57+00:00 https://www.pharmaceutical-business-review.com/news/d6493bausch__lomb_wins_approval_for_akreos_advanced_optics_aspheric/ 2018-07-04T16:02:57+00:00 https://www.pharmaceutical-business-review.com/news/114b0new_personalized_medicine_bill_introduced_in_us_con/ 2018-07-04T16:02:58+00:00 https://www.pharmaceutical-business-review.com/news/51497invitrogen_signs_us_distribution_agreement_with_biocare_me/ 2018-07-04T16:02:58+00:00 https://www.pharmaceutical-business-review.com/news/71480siga_wins_additional_funding_from_nih_for_lassa_antiviral_pr/ 2018-07-04T16:02:59+00:00 https://www.pharmaceutical-business-review.com/news/7c4a4kinex_pharmaceuticals_names_new_board_m/ 2018-07-04T16:02:59+00:00 https://www.pharmaceutical-business-review.com/news/8c4baothera_initiates_dosing_in_phase_iii_ocular_hypertension_and_glaucoma_/ 2018-07-04T16:03:00+00:00 https://www.pharmaceutical-business-review.com/news/89492roche_reports_positive_data_from_final_analysis_of_phase_iii_lung_cancer_/ 2018-07-04T16:03:00+00:00 https://www.pharmaceutical-business-review.com/news/6c4b1sequenom_expands_its_noninvasive_prenatal_diagnostic_ip_port/ 2018-07-04T16:03:00+00:00 https://www.pharmaceutical-business-review.com/news/8e485cequent_achieves_second_milestone_in_novartis_option_fund_agre/ 2018-07-04T16:03:02+00:00 https://www.pharmaceutical-business-review.com/news/6d492mdrna_appoints_ceo_as_board_member_and_pres/ 2018-07-04T16:03:02+00:00 https://www.pharmaceutical-business-review.com/news/324a1upstream_initiates_animal_efficacy_testing_for_trypanosomiasis_trea/ 2018-07-04T16:03:02+00:00 https://www.pharmaceutical-business-review.com/news/0e490bayer_wins_canadian_approval_for_new_oral_anticoag/ 2018-07-04T16:03:02+00:00 https://www.pharmaceutical-business-review.com/news/18492wright_medical_introduces_new_matrix_for_softtissue_repairs_in_foot_and_/ 2018-07-04T16:03:03+00:00 https://www.pharmaceutical-business-review.com/news/224b3direvo_biotech_sells_its_industrial_biotechnology_subsi/ 2018-07-04T16:03:04+00:00 https://www.pharmaceutical-business-review.com/news/c64a2prostrakan_wins_fda_approval_for_nausea_control_/ 2018-07-04T16:03:04+00:00 https://www.pharmaceutical-business-review.com/news/254bfbayer_healthcare_acquires_direvo_bi/ 2018-07-04T16:03:04+00:00 https://www.pharmaceutical-business-review.com/news/8b48cgentas_phase_iii_melanoma_study_receives_positive_review_fro/ 2018-07-04T16:03:05+00:00 https://www.pharmaceutical-business-review.com/news/514acbayer_to_introduce_new_needle_for_multiple_sclerosis_treatment_/ 2018-07-04T16:03:05+00:00 https://www.pharmaceutical-business-review.com/news/94485xoma_adds_new_programs_in_its_antibody_collaboration_with_t/ 2018-07-04T16:03:09+00:00 https://www.pharmaceutical-business-review.com/news/d8496dsm_and_libragen_to_codevelop_transaminases_for_production_of_chiral_a/ 2018-07-04T16:03:09+00:00 https://www.pharmaceutical-business-review.com/news/074a2siga_awarded_nih_grant_for_dengue_antiviral_pr/ 2018-07-04T16:03:09+00:00 https://www.pharmaceutical-business-review.com/news/124bbepicept_amends_bupivacaine_patch_licensing_agreement_with_d/ 2018-07-04T16:03:10+00:00 https://www.pharmaceutical-business-review.com/news/2c4bfoxygen_biotherapeutics_names_new_head_of_wound_care_div/ 2018-07-04T16:03:10+00:00 https://www.pharmaceutical-business-review.com/news/2c4beariad_signs_merger_agreement_with_ariad_gene_therape/ 2018-07-04T16:03:12+00:00 https://www.pharmaceutical-business-review.com/news/354b7alcon_introduces_acrysof_phakic_intraocular_lens_in_ge/ 2018-07-04T16:03:13+00:00 https://www.pharmaceutical-business-review.com/news/644b1varian_medical_systems_signs_mou_with_siloam_hosp/ 2018-07-04T16:03:13+00:00 https://www.pharmaceutical-business-review.com/news/87493us_court_vacates_teva_exclusivity_on_generic_antipsychotic/ 2018-07-04T16:03:13+00:00 https://www.pharmaceutical-business-review.com/news/8c496etrials_worldwide_names_new_secretary_an/ 2018-07-04T16:03:13+00:00 https://www.pharmaceutical-business-review.com/news/6a48aadvanced_medical_institute_begins_operations_/ 2018-07-04T16:03:15+00:00 https://www.pharmaceutical-business-review.com/news/67484sunshine_heart_wins_approval_to_initiate_feasibility_trial_of_cpulse_d/ 2018-07-04T16:03:15+00:00 https://www.pharmaceutical-business-review.com/news/0948ffougera_wins_fda_approval_for_clotrimazole_cream_u/ 2018-07-04T16:03:15+00:00 https://www.pharmaceutical-business-review.com/news/e7480ucb_wins_fda_approval_for_seizure/ 2018-07-04T16:03:15+00:00 https://www.pharmaceutical-business-review.com/news/0f493catalyst_pharmaceutical_announces_45_million_registered_direct_off/ 2018-07-04T16:03:16+00:00 https://www.pharmaceutical-business-review.com/news/8849fphotomedex_extends_omnilux_photodynamic_therapy_line_/ 2018-07-04T16:03:17+00:00 https://www.pharmaceutical-business-review.com/news/fd4aeacologixs_cartilage_drug_found_to_be_effective_in_preclinical_st/ 2018-07-04T16:03:17+00:00 https://www.pharmaceutical-business-review.com/news/fc4b1johnson__johnsons_vice_chairman_to_r/ 2018-07-04T16:03:17+00:00 https://www.pharmaceutical-business-review.com/news/714a9power3_medical_names_new_interi/ 2018-07-04T16:03:18+00:00 https://www.pharmaceutical-business-review.com/news/b94b1power_medical_signs_license_and_supply_agreements_with_intuitive_sur/ 2018-07-04T16:03:18+00:00 https://www.pharmaceutical-business-review.com/news/664b2biovitrum_to_acquire_kepivance_and_stemgen_from_/ 2018-07-04T16:03:19+00:00 https://www.pharmaceutical-business-review.com/news/f54a7omnisonics_signs_licensing_agreement_with_boston_scien/ 2018-07-04T16:03:19+00:00 https://www.pharmaceutical-business-review.com/news/12498sun_pharma_wins_fda_approval_for_generic_osteoporosis/ 2018-07-04T16:03:20+00:00 https://www.pharmaceutical-business-review.com/news/fa49amedivisor_announces_medicaid_approval_for_albumax/ 2018-07-04T16:03:20+00:00 https://www.pharmaceutical-business-review.com/news/2c4absimcere_pharmaceutical_group_announces_key_management_ch/ 2018-07-04T16:03:20+00:00 https://www.pharmaceutical-business-review.com/news/aa490neuro_kinetics_adds_two_independent_sales_representative_age/ 2018-07-04T16:03:21+00:00 https://www.pharmaceutical-business-review.com/news/c0484exosome_diagnostics_names_new_director_of_genetics_res/ 2018-07-04T16:03:22+00:00 https://www.pharmaceutical-business-review.com/news/4a482cerus_and_german_red_cross_to_collaborate_on_intercept_red_blood_cell_s/ 2018-07-04T16:03:22+00:00 https://www.pharmaceutical-business-review.com/news/154aadrais_pharmaceuticals_and_unibioscreen_partner_to_develop_new_cancer/ 2018-07-04T16:03:22+00:00 https://www.pharmaceutical-business-review.com/news/724belundbeck_files_nda_in_us_for_schizophrenia/ 2018-07-04T16:03:22+00:00 https://www.pharmaceutical-business-review.com/news/5249dghent_university_hospital_to_acquire_varians_rapidarc_techn/ 2018-07-04T16:03:27+00:00 https://www.pharmaceutical-business-review.com/news/564b3inovio_reports_positive_preclinical_results_of_dnabased_cancer_va/ 2018-07-04T16:03:27+00:00 https://www.pharmaceutical-business-review.com/news/10493decode_and_radboud_university_discover_common_variants_in_cancer_human_g/ 2018-07-04T16:03:27+00:00 https://www.pharmaceutical-business-review.com/news/b848famorfix_reports_new_finding_for_vcjd_blood_screening_/ 2018-07-04T16:03:27+00:00 https://www.pharmaceutical-business-review.com/news/704bacleveland_biolabs_wins_grant_for_research_in_mitigation_of_radiation_d/ 2018-07-04T16:03:28+00:00 https://www.pharmaceutical-business-review.com/news/d24bffda_warns_on_chinamade_infant_fo/ 2018-07-04T16:03:29+00:00 https://www.pharmaceutical-business-review.com/news/36485fda_approves_expanded_indications_of_mercks_gardasil_va/ 2018-07-04T16:03:29+00:00 https://www.pharmaceutical-business-review.com/news/e74a1fda_approves_talecriss_neurologic/ 2018-07-04T16:03:29+00:00 https://www.pharmaceutical-business-review.com/news/e54aenucletron_introduces_new_radiotherapy_sof/ 2018-07-04T16:03:30+00:00 https://www.pharmaceutical-business-review.com/news/b7483nicoxs_second_phase_iii_osteoarthritis_study_meets_end/ 2018-07-04T16:03:30+00:00 https://www.pharmaceutical-business-review.com/news/dc497fda_to_review_basileas_complete_response_to_ceftobiprole_nda_approvable_l/ 2018-07-04T16:03:31+00:00 https://www.pharmaceutical-business-review.com/news/6e48anovartis_granted_priority_review_for_malaria/ 2018-07-04T16:03:32+00:00 https://www.pharmaceutical-business-review.com/news/5f4b4allergan_reports_positive_results_from_phase_iii_botox_headache_t/ 2018-07-04T16:03:32+00:00 https://www.pharmaceutical-business-review.com/news/0e49ccyclacel_expands_phase_ii_sapacitabine_trial_to_include_mds_pat/ 2018-07-04T16:03:32+00:00 https://www.pharmaceutical-business-review.com/news/094actransition_therapeutics_initiates_dosing_in_phase_ii_diabetes_/ 2018-07-04T16:03:33+00:00 https://www.pharmaceutical-business-review.com/news/a04aacv_therapeutics_licenses_angina_drug_to_menarini_/ 2018-07-04T16:03:34+00:00 https://www.pharmaceutical-business-review.com/news/804b5valeant_pharmaceuticals_sells_certain_european_business_operations_to/ 2018-07-04T16:03:34+00:00 https://www.pharmaceutical-business-review.com/news/5c4bdst_jude_medical_wins_clearance_for_new_implantable_cardiac_mo/ 2018-07-04T16:03:35+00:00 https://www.pharmaceutical-business-review.com/news/53482monosol_rx_wins_new_patent_for_thin_film_techn/ 2018-07-04T16:03:35+00:00 https://www.pharmaceutical-business-review.com/news/3a481cerimon_reports_positive_results_from_phase_ii_study_of_topical_pain_/ 2018-07-04T16:03:35+00:00 https://www.pharmaceutical-business-review.com/news/4e4bdoculus_launches_topical_wound_drug_in_/ 2018-07-04T16:03:37+00:00 https://www.pharmaceutical-business-review.com/news/6748dzosanos_transdermal_patch_found_effective_in_phase_ii_osteoporosis_/ 2018-07-04T16:03:37+00:00 https://www.pharmaceutical-business-review.com/news/c94a2pressure_biosciences_and_usamriid_sign_research_agre/ 2018-07-04T16:03:37+00:00 https://www.pharmaceutical-business-review.com/news/7d4aajazz_pharmaceuticals_completes_first_phase_iii_study_of_fibromyalgia/ 2018-07-04T16:03:38+00:00 https://www.pharmaceutical-business-review.com/news/a34aaaccurays_cfo_re/ 2018-07-04T16:03:38+00:00 https://www.pharmaceutical-business-review.com/news/f6489inspire_to_begin_phase_i_study_of_glaucoma/ 2018-07-04T16:03:39+00:00 https://www.pharmaceutical-business-review.com/news/fb4besmart_disc_awarded_new_patent_for_spinal_disc_techn/ 2018-07-04T16:03:40+00:00 https://www.pharmaceutical-business-review.com/news/b5492minrad_announces_change_in_distribution_agreement_with_rxelite_hol/ 2018-07-04T16:03:40+00:00 https://www.pharmaceutical-business-review.com/news/f148ebioscrip_and_unitedhealthcare_to_terminate_specialty_services_con/ 2018-07-04T16:03:40+00:00 https://www.pharmaceutical-business-review.com/news/d74b9questcor_pharmaceuticals_names_ne/ 2018-07-04T16:03:41+00:00 https://www.pharmaceutical-business-review.com/news/a849fking_pharmaceuticals_to_begin_cash_tender_offer_for_alp/ 2018-07-04T16:03:45+00:00 https://www.pharmaceutical-business-review.com/news/a34a9akorn_signs_new_contract_manufacturing_supply_agre/ 2018-07-04T16:03:45+00:00 https://www.pharmaceutical-business-review.com/news/c74betrubion_wins_patent_opposition_against_genentech_and_biogen/ 2018-07-04T16:03:46+00:00 https://www.pharmaceutical-business-review.com/news/734a2cardiac_network_names_new_interi/ 2018-07-04T16:03:46+00:00 https://www.pharmaceutical-business-review.com/news/544bbgenesis_pharmaceuticals_wins_12_million_new_purchase_o/ 2018-07-04T16:03:46+00:00 https://www.pharmaceutical-business-review.com/news/52489sigmaaldrich_signs_distribution_agreement_with_isosci/ 2018-07-04T16:03:47+00:00 https://www.pharmaceutical-business-review.com/news/c84bccryolife_initiates_hemostase_distribution_in_f/ 2018-07-04T16:03:48+00:00 https://www.pharmaceutical-business-review.com/news/cd484china_sky_one_medical_acquires_peng_lai_jin_chuang_co/ 2018-07-04T16:03:48+00:00 https://www.pharmaceutical-business-review.com/news/2c4b1calando_pharmaceuticals_initiates_phase_ii_ovarian_cancer_/ 2018-07-04T16:03:48+00:00 https://www.pharmaceutical-business-review.com/news/564b1pharmacyclics_announces_key_management_ch/ 2018-07-04T16:03:49+00:00 https://www.pharmaceutical-business-review.com/news/13490tianyin_pharmaceutical_wins_chinese_approval_for_asthma/ 2018-07-04T16:03:50+00:00 https://www.pharmaceutical-business-review.com/news/34484merck_files_new_license_application_for_lung_cancer/ 2018-07-04T16:03:50+00:00 https://www.pharmaceutical-business-review.com/news/ec492xel_completes_development_of_prototype_transdermal_patch_for_alzhei/ 2018-07-04T16:03:51+00:00 https://www.pharmaceutical-business-review.com/news/3a4absciele_and_addrenex_report_positive_results_from_phase_iii_adhd_/ 2018-07-04T16:03:51+00:00 https://www.pharmaceutical-business-review.com/news/184a6circassia_reports_positive_data_from_phase_ii_study_of_antiallergy_techn/ 2018-07-04T16:03:51+00:00 https://www.pharmaceutical-business-review.com/news/cf4a7dor_biopharma_signs_collaboration_agreement_with_burnsadler_pharmaceut/ 2018-07-04T16:03:53+00:00 https://www.pharmaceutical-business-review.com/news/ac48bxenoport_to_initiate_phase_ii_study_of_spasm/ 2018-07-04T16:03:53+00:00 https://www.pharmaceutical-business-review.com/news/50499genentech_names_new_vice_president_of_neurosc/ 2018-07-04T16:03:54+00:00 https://www.pharmaceutical-business-review.com/news/13483quintiles_transnational_to_expand_singapore_opera/ 2018-07-04T16:03:54+00:00 https://www.pharmaceutical-business-review.com/news/d94acpluristem_therapeutics_concludes_preclinical_safety_studies_of_ischemia/ 2018-07-04T16:03:54+00:00 https://www.pharmaceutical-business-review.com/news/0349acook_medical_completes_enrollment_for_new_drugeluting_peripheral_/ 2018-07-04T16:03:56+00:00 https://www.pharmaceutical-business-review.com/news/2b48dscheringplough_announces_european_launch_of_anesthesiarecovery/ 2018-07-04T16:03:56+00:00 https://www.pharmaceutical-business-review.com/news/c7497cytomedix_names_new_vice_president_of_business_develo/ 2018-07-04T16:03:56+00:00 https://www.pharmaceutical-business-review.com/news/d54abcellzome_and_glaxosmithkline_form_research_all/ 2018-07-04T16:03:57+00:00 https://www.pharmaceutical-business-review.com/news/cb4bftexas_am_university_system_and_xoma_sign_mou_for_biopharma_res/ 2018-07-04T16:03:57+00:00 https://www.pharmaceutical-business-review.com/news/a6488solubest_names_ne/ 2018-07-04T16:03:58+00:00 https://www.pharmaceutical-business-review.com/news/c4497stallergenes_opens_new_pharmaceutical_production_unit_in_/ 2018-07-04T16:03:59+00:00 https://www.pharmaceutical-business-review.com/news/7c4adplexigen_names_new_president_an/ 2018-07-04T16:03:59+00:00 https://www.pharmaceutical-business-review.com/news/a34a9meridian_bioscience_signs_new_canadian_distribution_agreement_with_so/ 2018-07-04T16:03:59+00:00 https://www.pharmaceutical-business-review.com/news/9f4a9lifeline_biotechnologies_files_patent_for_new_breast_cancer_diagnostic_s/ 2018-07-04T16:04:00+00:00 https://www.pharmaceutical-business-review.com/news/644a0chemaphor_names_ne/ 2018-07-04T16:04:05+00:00 https://www.pharmaceutical-business-review.com/news/cc4aeorasure_technologies_names_new_vice_president_of_international_/ 2018-07-04T16:04:05+00:00 https://www.pharmaceutical-business-review.com/news/864b0encorium_group_names_ne/ 2018-07-04T16:04:06+00:00 https://www.pharmaceutical-business-review.com/news/664a3merck_wins_eu_positive_opinion_for_new_formulation_of_diabetes/ 2018-07-04T16:04:06+00:00 https://www.pharmaceutical-business-review.com/news/a14b0imvision_therapeutics_initiates_phase_i_cat_dander_allergy_/ 2018-07-04T16:04:06+00:00 https://www.pharmaceutical-business-review.com/news/06484sensory_medical_raises_25_million_in_series_a_fina/ 2018-07-04T16:04:08+00:00 https://www.pharmaceutical-business-review.com/news/b94a0amplimed_signs_licensing_agreement_with_handok_pharmaceut/ 2018-07-04T16:04:08+00:00 https://www.pharmaceutical-business-review.com/news/2b4aaproteon_wins_fast_track_designation_for_hemodialysis/ 2018-07-04T16:04:08+00:00 https://www.pharmaceutical-business-review.com/news/8849aapp_pharmaceuticals_acquired_by_fres/ 2018-07-04T16:04:09+00:00 https://www.pharmaceutical-business-review.com/news/8e4barexahn_wins_approval_to_initiate_phase_ii_study_of_depression/ 2018-07-04T16:04:09+00:00 https://www.pharmaceutical-business-review.com/news/614bbaltor_licenses_tcell_receptors_targeting_hiv_and_hcv_fro/ 2018-07-04T16:04:11+00:00 https://www.pharmaceutical-business-review.com/news/96481argos_therapeutics_initiates_phase_iia_kidney_cancer_/ 2018-07-04T16:04:11+00:00 https://www.pharmaceutical-business-review.com/news/4c4a4sinovac_launches_new_seasonal_influenza_va/ 2018-07-04T16:04:12+00:00 https://www.pharmaceutical-business-review.com/news/dc49ctranscend_medical_names_new_president_an/ 2018-07-04T16:04:12+00:00 https://www.pharmaceutical-business-review.com/news/2f492bristolmyers_and_astrazenecas_phase_iii_diabetes_drug_meets_study/ 2018-07-04T16:04:12+00:00 https://www.pharmaceutical-business-review.com/news/984aaalpharma_reports_positive_results_from_phase_iii_osteoarthritis_pain_/ 2018-07-04T16:04:14+00:00 https://www.pharmaceutical-business-review.com/news/35481metabolon_names_new_board_m/ 2018-07-04T16:04:14+00:00 https://www.pharmaceutical-business-review.com/news/f24b8hana_biosciencess_leukemia_study_to_proceed_to_full_enrol/ 2018-07-04T16:04:15+00:00 https://www.pharmaceutical-business-review.com/news/1f490asuragen_signs_licensing_agreement_with_focus_diagno/ 2018-07-04T16:04:15+00:00 https://www.pharmaceutical-business-review.com/news/71497medicinova_reports_positive_preliminary_results_from_phase_ii_asthma_/ 2018-07-04T16:04:15+00:00 https://www.pharmaceutical-business-review.com/news/c84acglaxosmithkline_names_ne/ 2018-07-04T16:04:24+00:00 https://www.pharmaceutical-business-review.com/news/324a8affitech_names_new_cha/ 2018-07-04T16:04:25+00:00 https://www.pharmaceutical-business-review.com/news/b64b1pfizer_to_withdraw_global_marketing_applications_for_dalbav/ 2018-07-04T16:04:25+00:00 https://www.pharmaceutical-business-review.com/news/1b4afxoma_wins_65_million_federal_contract_for_botulism_/ 2018-07-04T16:04:25+00:00 https://www.pharmaceutical-business-review.com/news/ff4b0thermogenesis_signs_distribution_agreement_with_celling_technol/ 2018-07-04T16:04:25+00:00 https://www.pharmaceutical-business-review.com/news/a3492tomotherapy_and_vision_rt_collaborate_to_expand_hiart_system_imaging_op/ 2018-07-04T16:04:29+00:00 https://www.pharmaceutical-business-review.com/news/d94b3tyrell_announces_corporate_name_c/ 2018-07-04T16:04:29+00:00 https://www.pharmaceutical-business-review.com/news/5e4beomeros_initiates_enrollment_in_phase_iii_study_of_ophthalmic/ 2018-07-04T16:04:29+00:00 https://www.pharmaceutical-business-review.com/news/884b0micardia_wins_fda_approval_for_dynaplasty_annuloplasty_de/ 2018-07-04T16:04:30+00:00 https://www.pharmaceutical-business-review.com/news/9749aaruna_biomedical_names_new_board_m/ 2018-07-04T16:04:30+00:00 https://www.pharmaceutical-business-review.com/news/9e4aeinternational_stem_cell_signs_distribution_agreement_with_mill/ 2018-07-04T16:04:34+00:00 https://www.pharmaceutical-business-review.com/news/9348cspinal_restoration_completes_enrollment_for_pilot_study_of_biostat_s/ 2018-07-04T16:04:35+00:00 https://www.pharmaceutical-business-review.com/news/95491oramed_and_eti_karle_to_conduct_phase_iib_study_of_oral_insulin/ 2018-07-04T16:04:35+00:00 https://www.pharmaceutical-business-review.com/news/0748anabi_and_niaid_collaborate_on_pentastaph_vaccine_res/ 2018-07-04T16:04:35+00:00 https://www.pharmaceutical-business-review.com/news/8e483xtend_medical_to_start_diabetic_patient_monitoring_pr/ 2018-07-04T16:04:35+00:00 https://www.pharmaceutical-business-review.com/news/c548eintarcia_names_new_vice_president_of_clinical_res/ 2018-07-04T16:04:38+00:00 https://www.pharmaceutical-business-review.com/news/0d4a2compumed_signs_agreement_with_any_lab_tes/ 2018-07-04T16:04:38+00:00 https://www.pharmaceutical-business-review.com/news/dd485epiphany_biosciences_to_continue_phase_ii_shingles_/ 2018-07-04T16:04:39+00:00 https://www.pharmaceutical-business-review.com/news/1b4bficts_names_new_cmo_and_vice_president_of_clinical_opera/ 2018-07-04T16:04:39+00:00 https://www.pharmaceutical-business-review.com/news/8a490nucletron_and_medical_university_of_vienna_extend_partne/ 2018-07-04T16:04:39+00:00 https://www.pharmaceutical-business-review.com/news/714b3canfite_licenses_arthritis_drug_to_kwang_dong_pharmaceu/ 2018-07-04T16:04:42+00:00 https://www.pharmaceutical-business-review.com/news/62494metabasis_names_new_vice_president_of_intellectual_pro/ 2018-07-04T16:04:42+00:00 https://www.pharmaceutical-business-review.com/news/ff493advanced_cell_technology_announces_cost_reduction_pr/ 2018-07-04T16:04:43+00:00 https://www.pharmaceutical-business-review.com/news/da486jennerex_raises_83_million_in_series_b_fina/ 2018-07-04T16:04:43+00:00 https://www.pharmaceutical-business-review.com/news/8a48bcardica_wins_fda_approval_to_market_proximal_anastomosis_s/ 2018-07-04T16:04:43+00:00 https://www.pharmaceutical-business-review.com/news/f849dzafgen_names_ne/ 2018-07-04T16:04:45+00:00 https://www.pharmaceutical-business-review.com/news/1b48elentigen_relocates_its_corporate_headqua/ 2018-07-04T16:04:45+00:00 https://www.pharmaceutical-business-review.com/news/03482cvbt_opens_phase_ii_heart_trial_for_patient_scre/ 2018-07-04T16:04:46+00:00 https://www.pharmaceutical-business-review.com/news/ea483innexus_biotechnology_names_new_board_m/ 2018-07-04T16:04:46+00:00 https://www.pharmaceutical-business-review.com/news/424batripos_to_acquire_pharsight_for_57_mi/ 2018-07-04T16:04:46+00:00 https://www.pharmaceutical-business-review.com/news/ab4aclrs_wins_approval_for_testing_hypothermia_device_in_brain_injury_/ 2018-07-04T16:04:49+00:00 https://www.pharmaceutical-business-review.com/news/0b49acharles_river_acquires_newlab_bioqu/ 2018-07-04T16:04:50+00:00 https://www.pharmaceutical-business-review.com/news/f548emillennium_pharmacy_systems_names_ne/ 2018-07-04T16:04:50+00:00 https://www.pharmaceutical-business-review.com/news/abingdon_life_sciences_names_new_vice_president_of_regulatory_science/ 2018-07-04T16:04:50+00:00 https://www.pharmaceutical-business-review.com/news/264bbbiosante_reports_positive_results_from_phase_ii_study_of_oral_contrace/ 2018-07-04T16:04:51+00:00 https://www.pharmaceutical-business-review.com/news/d64bepharmasset_reports_preliminary_results_from_phase_i_hepatitis_/ 2018-07-04T16:04:53+00:00 https://www.pharmaceutical-business-review.com/news/774b6biocon_reports_encouraging_results_from_oral_diabetes_drug_/ 2018-07-04T16:04:53+00:00 https://www.pharmaceutical-business-review.com/news/5f4a0epigenomics_reports_positive_interim_results_of_prostate_cancer_/ 2018-07-04T16:04:54+00:00 https://www.pharmaceutical-business-review.com/news/334abbausch__lomb_and_2010_perfect_vision_to_fo/ 2018-07-04T16:04:54+00:00 https://www.pharmaceutical-business-review.com/news/8c4bewyeth_pharmaceuticals_introduces_new_hemophilia/ 2018-07-04T16:04:54+00:00 https://www.pharmaceutical-business-review.com/news/df4basepracor_introduces_alvesco_inhalation_aerosol_/ 2018-07-04T16:04:56+00:00 https://www.pharmaceutical-business-review.com/news/02489cyclacel_names_new_board_m/ 2018-07-04T16:04:56+00:00 https://www.pharmaceutical-business-review.com/news/2448cnir_diagnostics_terminates_agreement_with_sh/ 2018-07-04T16:04:57+00:00 https://www.pharmaceutical-business-review.com/news/6f48bmedarex_receives_milestone_payment_from_p/ 2018-07-04T16:04:57+00:00 https://www.pharmaceutical-business-review.com/news/094a9perrigo_acquires_rights_to_sell_synthons_allergy/ 2018-07-04T16:04:57+00:00 https://www.pharmaceutical-business-review.com/news/ff48ctakeda_san_francisco_names_new_vice_president_of_antibody_res/ 2018-07-04T16:04:59+00:00 https://www.pharmaceutical-business-review.com/news/664aalogical_therapeutics_initiates_study_of_antiinflammatory/ 2018-07-04T16:04:59+00:00 https://www.pharmaceutical-business-review.com/news/a24acocimum_granted_new_us_patent_for_molecular_toxic/ 2018-07-04T16:05:00+00:00 https://www.pharmaceutical-business-review.com/news/c649eaptuit_names_ne/ 2018-07-04T16:05:00+00:00 https://www.pharmaceutical-business-review.com/news/0c4afoncolytics_biotech_initiates_enrollment_for_phase_ii_cancer_/ 2018-07-04T16:05:00+00:00 https://www.pharmaceutical-business-review.com/news/614a3salix_files_patent_infringement_lawsuit_against_novel_laborat/ 2018-07-04T16:05:02+00:00 https://www.pharmaceutical-business-review.com/news/7749eneogenix_names_new_president_an/ 2018-07-04T16:05:03+00:00 https://www.pharmaceutical-business-review.com/news/f94a3proteolix_secures_79_million_in_series_c_fina/ 2018-07-04T16:05:03+00:00 https://www.pharmaceutical-business-review.com/news/434b5ortho_biotech_files_snda_for_breast_cancer/ 2018-07-04T16:05:03+00:00 https://www.pharmaceutical-business-review.com/news/ba488asterand_signs_licensing_agreement_with_all/ 2018-07-04T16:05:04+00:00 https://www.pharmaceutical-business-review.com/news/0a49cfiveprime_therapeutics_initiates_enrollment_for_phase_i_cancer_/ 2018-07-04T16:05:06+00:00 https://www.pharmaceutical-business-review.com/news/2648dregenerx_completes_phase_ia_acute_myocardial_infarction_/ 2018-07-04T16:05:06+00:00 https://www.pharmaceutical-business-review.com/news/834bdboveran_diagnostics_signs_loi_to_acquire_sophora_diagnosti/ 2018-07-04T16:05:06+00:00 https://www.pharmaceutical-business-review.com/news/73486zosano_pharma_names_new_chairperson_an/ 2018-07-04T16:05:07+00:00 https://www.pharmaceutical-business-review.com/news/0e4b2fda_lists_drugs_under_safety_p/ 2018-07-04T16:05:07+00:00 https://www.pharmaceutical-business-review.com/news/b4484xoma_presents_positive_interim_data_from_phase_i_studies_of_diabetes/ 2018-07-04T16:05:10+00:00 https://www.pharmaceutical-business-review.com/news/c34a5novo_nordisk_reports_positive_results_from_phase_iii_study_of_diabetes_th/ 2018-07-04T16:05:10+00:00 https://www.pharmaceutical-business-review.com/news/6c493lifecell_international_names_new_executive_dir/ 2018-07-04T16:05:11+00:00 https://www.pharmaceutical-business-review.com/news/d2481biocis_pharma_obtains_e16_million_financing_for_phase_iii_dermatology_pr/ 2018-07-04T16:05:11+00:00 https://www.pharmaceutical-business-review.com/news/45494cytokinetics_presents_positive_interim_data_from_phase_iii_breast_cancer_/ 2018-07-04T16:05:11+00:00 https://www.pharmaceutical-business-review.com/news/59490novartiss_kidney_cancer_drug_granted_fda_priority_r/ 2018-07-04T16:05:13+00:00 https://www.pharmaceutical-business-review.com/news/30493tekmiras_partner_nci_presents_promising_data_on_liver_cancer_trea/ 2018-07-04T16:05:14+00:00 https://www.pharmaceutical-business-review.com/news/e44a0biomagnetics_diagnostics_forays_into_chinese_biotech_m/ 2018-07-04T16:05:14+00:00 https://www.pharmaceutical-business-review.com/news/d4481beacon_sciences_introduces_new_diagnostic_assay_for_creat/ 2018-07-04T16:05:14+00:00 https://www.pharmaceutical-business-review.com/news/1f4a5akorn_wins_approval_for_lyophilized_pr/ 2018-07-04T16:05:15+00:00 https://www.pharmaceutical-business-review.com/news/1749cnew_compound_from_amribristolmyers_squibb_collaboration_to_enter_develo/ 2018-07-04T16:05:17+00:00 https://www.pharmaceutical-business-review.com/news/7b4acmylan_to_retain_its_specialty_pharmaceutical_subsi/ 2018-07-04T16:05:17+00:00 https://www.pharmaceutical-business-review.com/news/2c4a9wrair_and_arbor_vita_sign_crada_for_traumatic_brain_i/ 2018-07-04T16:05:18+00:00 https://www.pharmaceutical-business-review.com/news/964banorth_american_scientific_divests_nontherapeutic_product/ 2018-07-04T16:05:18+00:00 https://www.pharmaceutical-business-review.com/news/boston_scientific_to_invest_e50m_in_galway_rd_facility_080908/ 2018-07-04T16:05:18+00:00 https://www.pharmaceutical-business-review.com/news/7b498orthofix_international_names_new_evp_an/ 2018-07-04T16:05:20+00:00 https://www.pharmaceutical-business-review.com/news/71496genomic_health_announces_supporting_data_for_breast_cancer_/ 2018-07-04T16:05:20+00:00 https://www.pharmaceutical-business-review.com/news/524b8colucid_reports_positive_results_from_phase_ii_study_of_migraine/ 2018-07-04T16:05:20+00:00 https://www.pharmaceutical-business-review.com/news/cd4a4neuraxon_reports_encouraging_results_from_phase_ii_migraine_/ 2018-07-04T16:05:21+00:00 https://www.pharmaceutical-business-review.com/news/ce4adaxial_biotech_names_new_vice_president_of_strategic_initia/ 2018-07-04T16:05:21+00:00 https://www.pharmaceutical-business-review.com/news/464b6arthrosurface_wins_approval_for_phase_iii_study_of_knee_resurfacing_im/ 2018-07-04T16:05:29+00:00 https://www.pharmaceutical-business-review.com/news/97498valley_baptist_health_system_selects_concuitys_payer_compliance_/ 2018-07-04T16:05:30+00:00 https://www.pharmaceutical-business-review.com/news/2348borthofix_wins_approvals_for_new_orthopedic_de/ 2018-07-04T16:05:30+00:00 https://www.pharmaceutical-business-review.com/news/6249bbostwick_wins_approval_to_initiate_phase_iii_prostate_cancer_/ 2018-07-04T16:05:30+00:00 https://www.pharmaceutical-business-review.com/news/6648ainvitrogen_names_new_senior_vice_president_an/ 2018-07-04T16:05:30+00:00 https://www.pharmaceutical-business-review.com/news/d0483sarcode_initiates_phase_i_ocular_inflammatory_diseases_/ 2018-07-04T16:05:33+00:00 https://www.pharmaceutical-business-review.com/news/2648bziopharm_initiates_phase_ii_sarcoma_/ 2018-07-04T16:05:33+00:00 https://www.pharmaceutical-business-review.com/news/45497questcor_names_two_new_vice_presi/ 2018-07-04T16:05:33+00:00 https://www.pharmaceutical-business-review.com/news/a44aepathway_medical_wins_fda_approval_for_jetstream_atherectomy_s/ 2018-07-04T16:05:34+00:00 https://www.pharmaceutical-business-review.com/news/d0499cytokinetics_initiates_phase_iia_heart_failure_/ 2018-07-04T16:05:34+00:00 https://www.pharmaceutical-business-review.com/news/1949amedlink_signs_distribution_agreement_with_medi/ 2018-07-04T16:05:37+00:00 https://www.pharmaceutical-business-review.com/news/cc4adintelgenx_technologies_names_ne/ 2018-07-04T16:05:37+00:00 https://www.pharmaceutical-business-review.com/news/rexahn-begins-patient-enrollment-for-depressive-disorder-study-260111/ 2018-07-04T16:05:38+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-allegra-as-otc-drug-sanofi-aventis-chattem-260111/ 2018-07-04T16:05:38+00:00 https://www.pharmaceutical-business-review.com/news/f648fhuifeng_signs_loi_with_xian_qinba_xintong_medi/ 2018-07-04T16:05:38+00:00 https://www.pharmaceutical-business-review.com/news/ad4a3northstar_names_new_vice_president_of_clinical_and_regulatory_af/ 2018-07-04T16:05:38+00:00 https://www.pharmaceutical-business-review.com/news/ca482glycomimetics_initiates_phase_i_sickle_cell_disease_/ 2018-07-04T16:05:38+00:00 https://www.pharmaceutical-business-review.com/news/watson-files-colesevelam-hci-powder-for-oral-suspension-anda-with-fda-260111/ 2018-07-04T16:05:39+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-pediatric-exclusivity-for-plavix-sanofi-aventis-bristol-myers-squibb-270111/ 2018-07-04T16:05:40+00:00 https://www.pharmaceutical-business-review.com/news/fda-issues-crl-for-avodart-snda-gsk-260111/ 2018-07-04T16:05:42+00:00 https://www.pharmaceutical-business-review.com/news/teva-pharma-acquires-infarmasa-260111/ 2018-07-04T16:05:42+00:00 https://www.pharmaceutical-business-review.com/news/61480progenics_initiates_phase_i_prostate_cancer_st/ 2018-07-04T16:05:42+00:00 https://www.pharmaceutical-business-review.com/news/ad4afesbatech_completes_phase_i_study_of_antibody_in_ophthalmic_indica/ 2018-07-04T16:05:42+00:00 https://www.pharmaceutical-business-review.com/news/404a4myconostica_introduces_new_fungal_pneumonia/ 2018-07-04T16:05:42+00:00 https://www.pharmaceutical-business-review.com/news/codexis-to-supply-biocatalysis-screening-products-to-dsp-250111/ 2018-07-04T16:05:43+00:00 https://www.pharmaceutical-business-review.com/news/294baorexo_and_boehringer_ingelheim_extend_research_partne/ 2018-07-04T16:05:43+00:00 https://www.pharmaceutical-business-review.com/news/2049cbasilea_pharmaceutica_wins_uk_approval_for_eczema/ 2018-07-04T16:05:43+00:00 https://www.pharmaceutical-business-review.com/news/labopharm-names-new-president-250111/ 2018-07-04T16:05:44+00:00 https://www.pharmaceutical-business-review.com/news/actient-pharma-takes-over-timm-medical-250111/ 2018-07-04T16:05:45+00:00 https://www.pharmaceutical-business-review.com/news/savient-pharma-appoints-new-ceo-250111/ 2018-07-04T16:05:45+00:00 https://www.pharmaceutical-business-review.com/news/jupiter-biosciences-in-talks-to-acquire-swiss-pharma-company-250111/ 2018-07-04T16:05:47+00:00 https://www.pharmaceutical-business-review.com/news/theratears-nutrition-improves-dry-eye-symptoms-advanced-vision-research-250111/ 2018-07-04T16:05:48+00:00 https://www.pharmaceutical-business-review.com/news/emergent-begins-phase-ibii-tru-016-study-250111/ 2018-07-04T16:05:49+00:00 https://www.pharmaceutical-business-review.com/news/mannatech-starts-business-operations-in-mexico-250111/ 2018-07-04T16:05:49+00:00 https://www.pharmaceutical-business-review.com/news/16499geneart_establishes_new_subsidiary_in_west_coast_/ 2018-07-04T16:05:51+00:00 https://www.pharmaceutical-business-review.com/news/kira-to-introduce-kira-pms-relief-kira-menopause-relief-250111/ 2018-07-04T16:05:51+00:00 https://www.pharmaceutical-business-review.com/news/uspto-issues-new-patent-to-progen-pharma-250111/ 2018-07-04T16:05:51+00:00 https://www.pharmaceutical-business-review.com/news/7d4a4celscis_rheumatoid_arthritis_vaccine_found_to_be_effective_in_animal_st/ 2018-07-04T16:05:52+00:00 https://www.pharmaceutical-business-review.com/news/7549dinverness_medical_introduces_new_portable_blood_testing_d/ 2018-07-04T16:05:52+00:00 https://www.pharmaceutical-business-review.com/news/45494medivisor_to_market_cura_pharmaceuticals_protein_isolate_fo/ 2018-07-04T16:05:52+00:00 https://www.pharmaceutical-business-review.com/news/524b7rosetta_genomics_identifies_potential_microrna_biomarkers_in_blood_/ 2018-07-04T16:05:52+00:00 https://www.pharmaceutical-business-review.com/news/takeda-pharma-millennium-commence-trinova-1-phase-iii-cancer-trial-250111/ 2018-07-04T16:05:52+00:00 https://www.pharmaceutical-business-review.com/news/quintiles-inaugurates-phase-i-research-facility-in-hyderabad-india-250111/ 2018-07-04T16:05:53+00:00 https://www.pharmaceutical-business-review.com/news/654adegenomics_wins_patent_for_dna_sequencing_techn/ 2018-07-04T16:05:54+00:00 https://www.pharmaceutical-business-review.com/news/a649eimmureboost_changes_name_to_fountain_healthy_/ 2018-07-04T16:05:54+00:00 https://www.pharmaceutical-business-review.com/news/034a4medistem_modifies_licensing_agreement_wit/ 2018-07-04T16:05:54+00:00 https://www.pharmaceutical-business-review.com/news/eisai-eritoran-fails-to-meet-primary-endpoint-in-phase-iii-trial-250111/ 2018-07-04T16:05:54+00:00 https://www.pharmaceutical-business-review.com/news/amgen-sets-to-take-over-biovex-250111/ 2018-07-04T16:05:54+00:00 https://www.pharmaceutical-business-review.com/news/8d48ebiospecifics_technologies_buys_down_royalties_for_peyronies_di/ 2018-07-04T16:05:55+00:00 https://www.pharmaceutical-business-review.com/news/0649fosprey_raises_11_million_in_private_fina/ 2018-07-04T16:05:55+00:00 https://www.pharmaceutical-business-review.com/news/furiex-receives-fda-fast-track-designation-for-ibs-drug-250111/ 2018-07-04T16:05:56+00:00 https://www.pharmaceutical-business-review.com/news/boston-scientific-concludes-patient-enrollment-in-evolve-clinical-trial-250111/ 2018-07-04T16:05:56+00:00 https://www.pharmaceutical-business-review.com/news/d6489regulus_therapeutics_names_new_board_m/ 2018-07-04T16:06:00+00:00 https://www.pharmaceutical-business-review.com/news/ae4b7axentis_pharma_initiates_phase_iia_cystic_fibrosis_/ 2018-07-04T16:06:00+00:00 https://www.pharmaceutical-business-review.com/news/matrix-receives-fda-approval-for-generic-protonix-250111/ 2018-07-04T16:06:00+00:00 https://www.pharmaceutical-business-review.com/news/health-market-science-alanda-introduce-completespend-version-30-250111/ 2018-07-04T16:06:00+00:00 https://www.pharmaceutical-business-review.com/news/15496abraxis_and_prometic_sign_license_agree/ 2018-07-04T16:06:01+00:00 https://www.pharmaceutical-business-review.com/news/0d491geneart_extends_strategic_partnership_with_q/ 2018-07-04T16:06:01+00:00 https://www.pharmaceutical-business-review.com/news/4e489healthscreen_names_ne/ 2018-07-04T16:06:01+00:00 https://www.pharmaceutical-business-review.com/news/torrent-pharma-to-start-formulations-facility-in-sikkim-250111/ 2018-07-04T16:06:02+00:00 https://www.pharmaceutical-business-review.com/news/novartis-to-acquire-personalized-diagnostic-services-provider-250111/ 2018-07-04T16:06:02+00:00 https://www.pharmaceutical-business-review.com/news/senesco-submits-ind-for-multiple-myeloma-drug-240111/ 2018-07-04T16:06:03+00:00 https://www.pharmaceutical-business-review.com/news/gsk-commences-two-phase-iii-studies-in-metastatic-melanoma-240111/ 2018-07-04T16:06:03+00:00 https://www.pharmaceutical-business-review.com/news/6f481csl_biotherapies_introduces_afluria_influenza_vaccine_/ 2018-07-04T16:06:04+00:00 https://www.pharmaceutical-business-review.com/news/be496premier_research_names_new_executive_dir/ 2018-07-04T16:06:05+00:00 https://www.pharmaceutical-business-review.com/news/1a490wolters_kluwer_health_to_acquire_upt/ 2018-07-04T16:06:05+00:00 https://www.pharmaceutical-business-review.com/news/614a9wright_medical_acquires_rayhack_wrist_reconstruction_s/ 2018-07-04T16:06:05+00:00 https://www.pharmaceutical-business-review.com/news/474a4merck_and_ablynx_partner_to_develop_nanobod/ 2018-07-04T16:06:05+00:00 https://www.pharmaceutical-business-review.com/news/northwest-restarts-patient-recruiting-in-dcvax-phase-ii-trial-210111/ 2018-07-04T16:06:05+00:00 https://www.pharmaceutical-business-review.com/news/raptor-pharma-concludes-patient-recruitment-in-phase-3-cystinosis-trial-240111/ 2018-07-04T16:06:05+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-gets-japanese-manufacturing-approval-for-ad-drug-240111/ 2018-07-04T16:06:06+00:00 https://www.pharmaceutical-business-review.com/news/biogen-idec-gets-chmp-negative-opinion-on-fampyra-240111/ 2018-07-04T16:06:06+00:00 https://www.pharmaceutical-business-review.com/news/eisai-breast-cancer-drug-gets-chmp-positive-opinion-240111/ 2018-07-04T16:06:08+00:00 https://www.pharmaceutical-business-review.com/news/904b8pharming_group_wins_fda_approval_for_kidney_transplantation_/ 2018-07-04T16:06:08+00:00 https://www.pharmaceutical-business-review.com/news/d34a7interleukin_and_access_business_group_sign_agreement_for_genetic_/ 2018-07-04T16:06:08+00:00 https://www.pharmaceutical-business-review.com/news/1049eidenix_completes_proofofconcept_study_for_hiv/ 2018-07-04T16:06:08+00:00 https://www.pharmaceutical-business-review.com/news/ross-unveils-new-mixing-system-210111/ 2018-07-04T16:06:08+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-prazaxa-receives-japanese-approval-240111/ 2018-07-04T16:06:09+00:00 https://www.pharmaceutical-business-review.com/news/de493sagent_secures_additional_30_million_in_series_a_fina/ 2018-07-04T16:06:09+00:00 https://www.pharmaceutical-business-review.com/news/ac4b6invitrogen_licenses_amplification_technology_to_three_life_science_comp/ 2018-07-04T16:06:09+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-pays-milestone-to-morphosys-240111/ 2018-07-04T16:06:10+00:00 https://www.pharmaceutical-business-review.com/news/sunshine-binghamton-university-to-develop-cancer-drug-240111/ 2018-07-04T16:06:11+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-pgxhealth-depressive-disorder-drug-viibryd-240111/ 2018-07-04T16:06:11+00:00 https://www.pharmaceutical-business-review.com/news/hms-gets-drummond-group-certification-for-electronic-health-record-240111/ 2018-07-04T16:06:12+00:00 https://www.pharmaceutical-business-review.com/news/454b2isis_granted_notices_of_allowance_for_new_rnatherapeutic_pa/ 2018-07-04T16:06:12+00:00 https://www.pharmaceutical-business-review.com/news/9249egtc_biotherapeuticss_thrombosis_drug_granted_fda_priority_r/ 2018-07-04T16:06:12+00:00 https://www.pharmaceutical-business-review.com/news/894bdmdrna_obtains_additional_350000_funding_fro/ 2018-07-04T16:06:12+00:00 https://www.pharmaceutical-business-review.com/news/c44afakela_pharma_wins_finnish_approval_to_initiate_phase_iii_cancer_pain_/ 2018-07-04T16:06:12+00:00 https://www.pharmaceutical-business-review.com/news/5b49aepix_to_regain_commercial_rights_for_vasovist_from_/ 2018-07-04T16:06:13+00:00 https://www.pharmaceutical-business-review.com/news/novartis-ms-drug-gilenya-receives-ema-chmp-positive-opinion-240111/ 2018-07-04T16:06:14+00:00 https://www.pharmaceutical-business-review.com/news/hamilton-peak-robotics-integrate-for-kinedx-robots-240111/ 2018-07-04T16:06:14+00:00 https://www.pharmaceutical-business-review.com/news/ba499acucela_and_otsuka_sign_codevelopment_agreement_for_amd/ 2018-07-04T16:06:15+00:00 https://www.pharmaceutical-business-review.com/news/hybrigenics-receives-positive-opinion-for-european-patent-on-high-therapeutic-doses-of-inecalcitol-240111/ 2018-07-04T16:06:15+00:00 https://www.pharmaceutical-business-review.com/news/novartis-inks-agreement-to-acquire-genoptix-240111/ 2018-07-04T16:06:15+00:00 https://www.pharmaceutical-business-review.com/news/a2498pharmaxis_initiates_enrollment_in_phase_iii_cystic_fibrosis_/ 2018-07-04T16:06:16+00:00 https://www.pharmaceutical-business-review.com/news/a048bantisoma_initiates_phase_ii_kidney_cancer_/ 2018-07-04T16:06:16+00:00 https://www.pharmaceutical-business-review.com/news/40483agiles_phase_iib_contraceptive_patch_study_meets_end/ 2018-07-04T16:06:16+00:00 https://www.pharmaceutical-business-review.com/news/e94b8diffusion_pharmaceuticals_initiates_enrollment_in_phase_iii_pad_/ 2018-07-04T16:06:17+00:00 https://www.pharmaceutical-business-review.com/news/purdue-pharma-introduced-butrans-transdermal-system-ciii-210111/ 2018-07-04T16:06:17+00:00 https://www.pharmaceutical-business-review.com/news/h-lundbeck-initiates-zicronapine-phase-iii-clinical-trial-210111/ 2018-07-04T16:06:17+00:00 https://www.pharmaceutical-business-review.com/news/regeneration-expands-humic-fulvic-minerals-product-line-210111/ 2018-07-04T16:06:18+00:00 https://www.pharmaceutical-business-review.com/news/eisai-gets-nerbloc-marketing-approval-in-japan-210111/ 2018-07-04T16:06:18+00:00 https://www.pharmaceutical-business-review.com/news/434a0sangamo_biosciences_initiates_phase_ii_als_/ 2018-07-04T16:06:19+00:00 https://www.pharmaceutical-business-review.com/news/04482roche_wins_fda_approval_for_hepatitis_b_viral_load/ 2018-07-04T16:06:19+00:00 https://www.pharmaceutical-business-review.com/news/88484nanotherapeutics_files_ind_for_diabetic_ulcer/ 2018-07-04T16:06:20+00:00 https://www.pharmaceutical-business-review.com/news/2f485hgs_signs_development_and_manufacturing_deal_with_ho/ 2018-07-04T16:06:20+00:00 https://www.pharmaceutical-business-review.com/news/15496panacea_wins_new_us_patent_for_antihaah_antib/ 2018-07-04T16:06:20+00:00 https://www.pharmaceutical-business-review.com/news/alliqua-finishes-transdermal-pain-patch-initial-study-210111/ 2018-07-04T16:06:20+00:00 https://www.pharmaceutical-business-review.com/news/ym-biosciences-releases-gastric-cancer-phase-ii-trial-results-210111/ 2018-07-04T16:06:20+00:00 https://www.pharmaceutical-business-review.com/news/fda-warns-against-ed-drug-man-up-now-210111/ 2018-07-04T16:06:21+00:00 https://www.pharmaceutical-business-review.com/news/health-alert-communications-presents-new-study-on-aids-epidemic-210111/ 2018-07-04T16:06:21+00:00 https://www.pharmaceutical-business-review.com/news/2a48dq_pharma_names_new_vice_president_of_sales_and_mark/ 2018-07-04T16:06:22+00:00 https://www.pharmaceutical-business-review.com/news/f349anatrix_separations_secures_19_million_in_series_b_fina/ 2018-07-04T16:06:22+00:00 https://www.pharmaceutical-business-review.com/news/254b5quatrx_initiates_phase_iii_postmenopausal_vaginal_syndrome_/ 2018-07-04T16:06:22+00:00 https://www.pharmaceutical-business-review.com/news/dc4aasynageva_names_new_ceo_and_opens_new_headqua/ 2018-07-04T16:06:22+00:00 https://www.pharmaceutical-business-review.com/news/18481pall_corporation_acquires_genesy/ 2018-07-04T16:06:23+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-introduces-generic-protonix-tablets-in-us-210111/ 2018-07-04T16:06:23+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-to-take-over-paddock-laboratories-210111/ 2018-07-04T16:06:23+00:00 https://www.pharmaceutical-business-review.com/news/matrix-gets-fda-tentative-approval-for-lamivudine-zidovudine-tablets-210111/ 2018-07-04T16:06:24+00:00 https://www.pharmaceutical-business-review.com/news/bioclinica-in-pact-with-symbiance-210111/ 2018-07-04T16:06:24+00:00 https://www.pharmaceutical-business-review.com/news/a74b2elan_and_biogen_initiate_first_phase_iii_myeloma_/ 2018-07-04T16:06:25+00:00 https://www.pharmaceutical-business-review.com/news/674b3azaya_licenses_new_technology_for_head_and_neck_cancer_trea/ 2018-07-04T16:06:25+00:00 https://www.pharmaceutical-business-review.com/news/e94a9ucbs_antiepileptic_drug_wins_european_app/ 2018-07-04T16:06:26+00:00 https://www.pharmaceutical-business-review.com/news/514a3cumberland_pharmaceuticals_names_new_svp_of_commercial_develo/ 2018-07-04T16:06:26+00:00 https://www.pharmaceutical-business-review.com/news/f948asinobiomed_names_new_director_of_strategic_develo/ 2018-07-04T16:06:26+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-status-to-rivax-soligenix-200111/ 2018-07-04T16:06:26+00:00 https://www.pharmaceutical-business-review.com/news/unity-management-signs-distribution-agreement-with-bd-italia-tablet-tooling-200111/ 2018-07-04T16:06:26+00:00 https://www.pharmaceutical-business-review.com/news/sma-foundation-rbm-join-hands-on-biomarker-panels-200111/ 2018-07-04T16:06:27+00:00 https://www.pharmaceutical-business-review.com/news/4sc-doses-first-patient-in-phase-iii-shore-study-200111/ 2018-07-04T16:06:27+00:00 https://www.pharmaceutical-business-review.com/news/a7486emergent_wins_243_million_contract_for_anthrax_antibody_develo/ 2018-07-04T16:06:28+00:00 https://www.pharmaceutical-business-review.com/news/c74b0genetix_group_wins_cytogenetics_contract_from_nhs_sco/ 2018-07-04T16:06:28+00:00 https://www.pharmaceutical-business-review.com/news/ad4b6alte_bioscience_files_patent_for_new_inflammatory_bowel_disease_/ 2018-07-04T16:06:29+00:00 https://www.pharmaceutical-business-review.com/news/934a0gamma_wins_certificate_of_hygiene_for_products_in_/ 2018-07-04T16:06:29+00:00 https://www.pharmaceutical-business-review.com/news/b34b2acesys_and_provid_form_alliance_for_medicinal_chemistry_ser/ 2018-07-04T16:06:29+00:00 https://www.pharmaceutical-business-review.com/news/evotec-signs-pact-with-takeda-cambridge-200111/ 2018-07-04T16:06:33+00:00 https://www.pharmaceutical-business-review.com/news/amrutanjan-austin-chemical-sign-mou-200111/ 2018-07-04T16:06:33+00:00 https://www.pharmaceutical-business-review.com/news/944acneurologix_licenses_key_gene_from_aegera_therape/ 2018-07-04T16:06:34+00:00 https://www.pharmaceutical-business-review.com/news/a1494agendia_introduces_new_breast_cancer_diagnostic/ 2018-07-04T16:06:34+00:00 https://www.pharmaceutical-business-review.com/news/fa4a7metropolitan_health_networks_amends_agreement_with_h/ 2018-07-04T16:06:34+00:00 https://www.pharmaceutical-business-review.com/news/e1492aegerion_names_new_board_m/ 2018-07-04T16:06:34+00:00 https://www.pharmaceutical-business-review.com/news/5548asubsidiaries_of_zimmer_holdings_to_acquire_abbott_/ 2018-07-04T16:06:35+00:00 https://www.pharmaceutical-business-review.com/news/targacept-reports-positive-schizophrenia-drug-study-200111/ 2018-07-04T16:06:35+00:00 https://www.pharmaceutical-business-review.com/news/biomarin-begins-pompe-disease-drug-study-200111/ 2018-07-04T16:06:35+00:00 https://www.pharmaceutical-business-review.com/news/fda-issues-crl-to-mannkind-afrezza-nda-200111/ 2018-07-04T16:06:36+00:00 https://www.pharmaceutical-business-review.com/news/genzyme-to-establish-new-drug-manufacturing-plant-in-belgium-200111/ 2018-07-04T16:06:37+00:00 https://www.pharmaceutical-business-review.com/news/1c4adcelator_receives_orphan_drug_designation_for_leukemia/ 2018-07-04T16:06:38+00:00 https://www.pharmaceutical-business-review.com/news/86495cytopia_initiates_enrollment_for_second_phase_ii_brain_cancer_/ 2018-07-04T16:06:38+00:00 https://www.pharmaceutical-business-review.com/news/5e4b4nxstage_extends_blood_tubing_set_agreement_with_d/ 2018-07-04T16:06:38+00:00 https://www.pharmaceutical-business-review.com/news/94484pathwork_diagnostics_raises_20_million_in_fina/ 2018-07-04T16:06:38+00:00 https://www.pharmaceutical-business-review.com/news/teletracking-updates-transfercenter-software-200111/ 2018-07-04T16:06:38+00:00 https://www.pharmaceutical-business-review.com/news/pharmavigilant-introduces-i-warehouse-30-200111/ 2018-07-04T16:06:38+00:00 https://www.pharmaceutical-business-review.com/news/534a8bilcare_expands_phase_iii_clinical_trial_service_capabil/ 2018-07-04T16:06:39+00:00 https://www.pharmaceutical-business-review.com/news/cellectis-signs-license-pact-university-of-minnesota-200111/ 2018-07-04T16:06:40+00:00 https://www.pharmaceutical-business-review.com/news/ziopharm-receives-positive-opinion-from-ema-for-darinaparsin-200111/ 2018-07-04T16:06:40+00:00 https://www.pharmaceutical-business-review.com/news/meda-launches-acute-myeloid-leukaemia-drug-ceplene-200111/ 2018-07-04T16:06:41+00:00 https://www.pharmaceutical-business-review.com/news/ed493celgene_receives_fda_fast_track_designation_for_lung_cancer/ 2018-07-04T16:06:41+00:00 https://www.pharmaceutical-business-review.com/news/7b4b2biocryst_reports_positive_results_from_phase_iia_psoriasis_/ 2018-07-04T16:06:41+00:00 https://www.pharmaceutical-business-review.com/news/d64b5bioms_wins_fda_fast_track_designation_for_multiple_sclerosis/ 2018-07-04T16:06:41+00:00 https://www.pharmaceutical-business-review.com/news/9248equinnova_names_new_senior_vice_president_o/ 2018-07-04T16:06:41+00:00 https://www.pharmaceutical-business-review.com/news/archimedes-signs-research-agreement-with-fda-200111/ 2018-07-04T16:06:42+00:00 https://www.pharmaceutical-business-review.com/news/fb4b8human_genome_sciences_reports_initial_results_from_phase_ii_myeloma_/ 2018-07-04T16:06:42+00:00 https://www.pharmaceutical-business-review.com/news/assura-group-to-acquire-ah-medical-properties-200111/ 2018-07-04T16:06:43+00:00 https://www.pharmaceutical-business-review.com/news/gsk-prosensa-treat-first-patient-in-dmd-trial-190111/ 2018-07-04T16:06:43+00:00 https://www.pharmaceutical-business-review.com/news/c949bconvatec_acquires_unome/ 2018-07-04T16:06:43+00:00 https://www.pharmaceutical-business-review.com/news/geron-recruits-first-patient-in-imetelstat-phase-2-trial-190111/ 2018-07-04T16:06:44+00:00 https://www.pharmaceutical-business-review.com/news/174acipsogen_names_new_president_for_its_us_subsi/ 2018-07-04T16:06:44+00:00 https://www.pharmaceutical-business-review.com/news/884baneurocrine_reports_positive_results_from_phase_ii_endometriosis_/ 2018-07-04T16:06:44+00:00 https://www.pharmaceutical-business-review.com/news/314b6cosmederm_signs_licensing_and_distribution_agreement_with_dr_re/ 2018-07-04T16:06:44+00:00 https://www.pharmaceutical-business-review.com/news/theraclone-pfizer-ink-research-pact-190111/ 2018-07-04T16:06:45+00:00 https://www.pharmaceutical-business-review.com/news/214b2bristolmyers_and_pfizer_report_encouraging_results_for_phase_ii_acs_/ 2018-07-04T16:06:45+00:00 https://www.pharmaceutical-business-review.com/news/glenmark-pharma-gets-fda-approval-to-market-generic-malaria-drug-190111/ 2018-07-04T16:06:47+00:00 https://www.pharmaceutical-business-review.com/news/cadence-pharma-launches-ofirmev-in-us-190111/ 2018-07-04T16:06:48+00:00 https://www.pharmaceutical-business-review.com/news/gsk-treats-first-patient-in-phase-iii-intravenous-zanamivir-trial-190111/ 2018-07-04T16:06:51+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-parapro-head-lice-medication-190111/ 2018-07-04T16:06:51+00:00 https://www.pharmaceutical-business-review.com/news/04492adolor_regains_rights_to_entereg_for_opioid_bowel_dysfun/ 2018-07-04T16:06:51+00:00 https://www.pharmaceutical-business-review.com/news/1f4acboston_scientific_reports_positive_data_from_taxus_olympia_reg/ 2018-07-04T16:06:51+00:00 https://www.pharmaceutical-business-review.com/news/a84a1intermune_receives_15_million_milestone_payment_from_/ 2018-07-04T16:06:51+00:00 https://www.pharmaceutical-business-review.com/news/4f4afnorth_american_scientific_to_divest_nontherapeutic_product/ 2018-07-04T16:06:51+00:00 https://www.pharmaceutical-business-review.com/news/f7493cv_therapeutics_initiates_enrollment_in_phase_i_cardiometabolic_diseases_/ 2018-07-04T16:06:52+00:00 https://www.pharmaceutical-business-review.com/news/074acfibrex_reports_positive_results_from_phase_ii_reperfusion_injury_/ 2018-07-04T16:06:53+00:00 https://www.pharmaceutical-business-review.com/news/jsc-pharmstandard-acquires-55-stake-in-pjsc-biolek-190111/ 2018-07-04T16:06:53+00:00 https://www.pharmaceutical-business-review.com/news/prolor-biotech-inks-agreement-with-yeda-190111/ 2018-07-04T16:06:53+00:00 https://www.pharmaceutical-business-review.com/news/414b2sucampo_pharmaceuticals_names_new_head_of_business_develo/ 2018-07-04T16:06:54+00:00 https://www.pharmaceutical-business-review.com/news/de4a9invitrogen_and_cytovance_partner_to_develop_new_bioreactor_pr/ 2018-07-04T16:06:54+00:00 https://www.pharmaceutical-business-review.com/news/79491tomotherapy_names_new_board_m/ 2018-07-04T16:06:54+00:00 https://www.pharmaceutical-business-review.com/news/c14a8ricerca_biosciences_names_new_executive_vice_president_an/ 2018-07-04T16:06:54+00:00 https://www.pharmaceutical-business-review.com/news/anavex-supports-national-alzheimers-project-act-190111/ 2018-07-04T16:06:55+00:00 https://www.pharmaceutical-business-review.com/news/monosol-rx-files-false-marking-lawsuit-against-bdsi-meda-aveva-190111/ 2018-07-04T16:06:55+00:00 https://www.pharmaceutical-business-review.com/news/cambrex-indian-manufacturing-facility-receives-dkma-approval-190111/ 2018-07-04T16:07:00+00:00 https://www.pharmaceutical-business-review.com/news/kyoto-university-takeda-to-develop-drugs-for-obesity-schizophrenia-190111/ 2018-07-04T16:07:01+00:00 https://www.pharmaceutical-business-review.com/news/ariad-soft-tissue-sarcoma-drug-meets-primary-endpoint-190111/ 2018-07-04T16:07:03+00:00 https://www.pharmaceutical-business-review.com/news/ironwood-pharma-protagonist-sign-peptide-drug-discovery-pact-190111/ 2018-07-04T16:07:03+00:00 https://www.pharmaceutical-business-review.com/news/ec4acantares_pharma_signs_development_agreement_with_dr_re/ 2018-07-04T16:07:08+00:00 https://www.pharmaceutical-business-review.com/news/8a4b3osi_pharmaceuticals_initiates_diabetes_drug_development_pr/ 2018-07-04T16:07:08+00:00 https://www.pharmaceutical-business-review.com/news/0f4beterumo_files_patent_infringement_complaint_against_maquet_cardiovas/ 2018-07-04T16:07:08+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-to-acquire-amgen-fremont-california-facility-190111/ 2018-07-04T16:07:08+00:00 https://www.pharmaceutical-business-review.com/news/bspc-chooses-extedo-ectdmanager-suite-190111/ 2018-07-04T16:07:08+00:00 https://www.pharmaceutical-business-review.com/news/ca48dendo_pharmaceuticals_cfo_re/ 2018-07-04T16:07:09+00:00 https://www.pharmaceutical-business-review.com/news/214a0merck_and_zymogenetics_restructure_research_partne/ 2018-07-04T16:07:09+00:00 https://www.pharmaceutical-business-review.com/news/harbor-biosciences-licenses-three-compounds-to-cipi-190111/ 2018-07-04T16:07:10+00:00 https://www.pharmaceutical-business-review.com/news/microbix-names-new-ceo-chairman-for-hunanmicrobix-joint-venture-200111/ 2018-07-04T16:07:10+00:00 https://www.pharmaceutical-business-review.com/news/c94abpfizer_signs_development_and_marketing_agreement_with_mediv/ 2018-07-04T16:07:11+00:00 https://www.pharmaceutical-business-review.com/news/804b5opexa_and_mrf_collaborate_on_multiple_sclerosis_research_pr/ 2018-07-04T16:07:11+00:00 https://www.pharmaceutical-business-review.com/news/484baalexzas_phase_iii_agitation_study_meets_end/ 2018-07-04T16:07:11+00:00 https://www.pharmaceutical-business-review.com/news/curefaktor-pharma-pancreatic-cancer-treatment-gets-orphan-drug-status-180111/ 2018-07-04T16:07:11+00:00 https://www.pharmaceutical-business-review.com/news/2c496threshold_pharmaceuticals_raises_18_million_in_equity_fina/ 2018-07-04T16:07:12+00:00 https://www.pharmaceutical-business-review.com/news/4e4b0siga_technologies_wins_55_million_federal_con/ 2018-07-04T16:07:12+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-final-approval-for-acarbose-tablets-anda-mylan-pharma-180111/ 2018-07-04T16:07:12+00:00 https://www.pharmaceutical-business-review.com/news/r5-pharma-to-expand-operations-180111/ 2018-07-04T16:07:13+00:00 https://www.pharmaceutical-business-review.com/news/covidien-launches-everflex-stent-system-in-europe-180111/ 2018-07-04T16:07:13+00:00 https://www.pharmaceutical-business-review.com/news/vertellus-specialties-vapi-products-establish-joint-venture-180111/ 2018-07-04T16:07:14+00:00 https://www.pharmaceutical-business-review.com/news/pharmagraphics-guy-installs-new-vision-verification-technology-180111/ 2018-07-04T16:07:15+00:00 https://www.pharmaceutical-business-review.com/news/87484neurotech_wins_fast_track_designations_for_intraocular/ 2018-07-04T16:07:15+00:00 https://www.pharmaceutical-business-review.com/news/67495corcept_therapeutics_and_lilly_continue_collabor/ 2018-07-04T16:07:15+00:00 https://www.pharmaceutical-business-review.com/news/transpharma-rebrands-viaderm-to-viador-180111/ 2018-07-04T16:07:16+00:00 https://www.pharmaceutical-business-review.com/news/smc-accepts-use-of-pecfent-in-scotland-archimedes-pharma-180111/ 2018-07-04T16:07:16+00:00 https://www.pharmaceutical-business-review.com/news/4d48bhalozyme_therapeutics_names_three_new_execu/ 2018-07-04T16:07:16+00:00 https://www.pharmaceutical-business-review.com/news/d5493united_therapeuticss_nda_for_inhaled_treprostinil_accepted_for_fda_r/ 2018-07-04T16:07:16+00:00 https://www.pharmaceutical-business-review.com/news/ff496us_oncology_launches_new_cancer_services_div/ 2018-07-04T16:07:16+00:00 https://www.pharmaceutical-business-review.com/news/ecron-acunova-extends-clinical-research-centre-for-drug-development-180111/ 2018-07-04T16:07:17+00:00 https://www.pharmaceutical-business-review.com/news/cook-medical-presents-drug-eluting-peripheral-stent-trial-results-180111/ 2018-07-04T16:07:18+00:00 https://www.pharmaceutical-business-review.com/news/0f4b5anadis_wins_israeli_approval_for_cancerrelated_mucositis_pr/ 2018-07-04T16:07:18+00:00 https://www.pharmaceutical-business-review.com/news/5448ctarganta_reports_positive_results_from_phase_ii_skin_infections_/ 2018-07-04T16:07:18+00:00 https://www.pharmaceutical-business-review.com/news/regeneron-bayer-healthcare-begin-retinal-disease-drug-study-180111/ 2018-07-04T16:07:19+00:00 https://www.pharmaceutical-business-review.com/news/cook-medical-reveals-reform-clinical-trial-data-on-renal-stent-180111/ 2018-07-04T16:07:19+00:00 https://www.pharmaceutical-business-review.com/news/c64b9protox_completes_enrollment_for_phase_ii_benign_prostatic_hyperplasia_/ 2018-07-04T16:07:19+00:00 https://www.pharmaceutical-business-review.com/news/5849cmillipore_and_agilent_technologies_collaborate_in_epigenetics_res/ 2018-07-04T16:07:19+00:00 https://www.pharmaceutical-business-review.com/news/e34a6osprey_pharmaceuticals_secures_11_million_in_fina/ 2018-07-04T16:07:19+00:00 https://www.pharmaceutical-business-review.com/news/faron-pharma-rentschler-sign-supply-manufacturing-pact-180111/ 2018-07-04T16:07:21+00:00 https://www.pharmaceutical-business-review.com/news/japanese-patent-office-grants-new-patent-for-ser100-seordus-180111/ 2018-07-04T16:07:21+00:00 https://www.pharmaceutical-business-review.com/news/e648eplexxikon_initiates_phase_i_study_of_new_drug_for_pain_and_renal_di/ 2018-07-04T16:07:21+00:00 https://www.pharmaceutical-business-review.com/news/3c486big_pharma_keen_on_partnering_with_aca/ 2018-07-04T16:07:21+00:00 https://www.pharmaceutical-business-review.com/news/src-unveils-clinical-information-toolkit-180111/ 2018-07-04T16:07:22+00:00 https://www.pharmaceutical-business-review.com/news/biostorage-releases-isiss-latest-version-180111/ 2018-07-04T16:07:22+00:00 https://www.pharmaceutical-business-review.com/news/b34b1edwards_lifesciences_wins_fda_approval_for_new_mitral_heart_/ 2018-07-04T16:07:22+00:00 https://www.pharmaceutical-business-review.com/news/574a8helix_biomedix_signs_licensing_agreement_with_rodan___fields_dermatolo/ 2018-07-04T16:07:22+00:00 https://www.pharmaceutical-business-review.com/news/25490rexahn_pharmaceuticals_wins_new_cancer_p/ 2018-07-04T16:07:22+00:00 https://www.pharmaceutical-business-review.com/news/sanford-burnham-signs-agreement-with-omjpi-180111/ 2018-07-04T16:07:23+00:00 https://www.pharmaceutical-business-review.com/news/univar-to-acquire-eral-protek-170111/ 2018-07-04T16:07:24+00:00 https://www.pharmaceutical-business-review.com/news/454b9integral_molecular_initiates_nihfunded_program_for_influenza_drug_disc/ 2018-07-04T16:07:24+00:00 https://www.pharmaceutical-business-review.com/news/d348fbiovail_files_anda_for_fenofibrate_ta/ 2018-07-04T16:07:24+00:00 https://www.pharmaceutical-business-review.com/news/chugai-grants-vegf-d-intellectual-property-license-to-circadian-170111/ 2018-07-04T16:07:25+00:00 https://www.pharmaceutical-business-review.com/news/e8493ikaria_acquires_rights_to_orphan_therapeuticss_liver/ 2018-07-04T16:07:25+00:00 https://www.pharmaceutical-business-review.com/news/4a49bwellspring_acquires_consumer_product_brands_from_m/ 2018-07-04T16:07:25+00:00 https://www.pharmaceutical-business-review.com/news/9848banesiva_names_new_chief_medical_of/ 2018-07-04T16:07:25+00:00 https://www.pharmaceutical-business-review.com/news/domain-therapeutics-merck-serono-to-develop-parkinsons-disease-drugs-170111/ 2018-07-04T16:07:26+00:00 https://www.pharmaceutical-business-review.com/news/diamyd-doses-first-patient-in-cancer-pain-drug-phase-ii-clinical-trial-170111/ 2018-07-04T16:07:27+00:00 https://www.pharmaceutical-business-review.com/news/mcneil-consumer-healthcare-voluntarily-recalls-certain-otc-products-170111/ 2018-07-04T16:07:27+00:00 https://www.pharmaceutical-business-review.com/news/9049balpha_innotech_signs_supplier_alliance_agreement_with_ge_healt/ 2018-07-04T16:07:31+00:00 https://www.pharmaceutical-business-review.com/news/actavis-inaugurates-new-manufacturing-plant-210111/ 2018-07-04T16:07:32+00:00 https://www.pharmaceutical-business-review.com/news/abbott-pulls-us-european-applications-for-psoriasis-drug-briakinumab-170111/ 2018-07-04T16:07:32+00:00 https://www.pharmaceutical-business-review.com/news/194bfmap_pharmaceuticals_announces_new_appoin/ 2018-07-04T16:07:32+00:00 https://www.pharmaceutical-business-review.com/news/474b5genelabs_technologies_appoints_president_an/ 2018-07-04T16:07:32+00:00 https://www.pharmaceutical-business-review.com/news/6d48fbioimagene_appoints_chief_medical_of/ 2018-07-04T16:07:32+00:00 https://www.pharmaceutical-business-review.com/news/c04a6stentys_names_chief_medical_of/ 2018-07-04T16:07:32+00:00 https://www.pharmaceutical-business-review.com/news/piab-adds-smaller-suction-cups-to-duraflex-bx-range-170111/ 2018-07-04T16:07:34+00:00 https://www.pharmaceutical-business-review.com/news/health-canada-requests-osiris-additional-information-on-stem-cell-therapy-prochymal-170111/ 2018-07-04T16:07:34+00:00 https://www.pharmaceutical-business-review.com/news/bathing-tumor-ridden-livers-in-chemotherapy-limits-toxic-side-effects-new-study-170111/ 2018-07-04T16:07:35+00:00 https://www.pharmaceutical-business-review.com/news/generic-drug-market-set-to-witness-major-growth-in-eu-genmed-170111/ 2018-07-04T16:07:35+00:00 https://www.pharmaceutical-business-review.com/news/ab4b6oncogenex_licenses_cancer_drug_to_eagle_pharmaceut/ 2018-07-04T16:07:35+00:00 https://www.pharmaceutical-business-review.com/news/c34bcpain_therapeutics_receives_20_million_from_king_pharmaceut/ 2018-07-04T16:07:36+00:00 https://www.pharmaceutical-business-review.com/news/9649dalpharmas_pain_drug_granted_fda_priority_r/ 2018-07-04T16:07:36+00:00 https://www.pharmaceutical-business-review.com/news/2c498idera_to_receive_milestone_payment_from_nov/ 2018-07-04T16:07:36+00:00 https://www.pharmaceutical-business-review.com/news/b74bfoncothyreon_to_offer_51_million_shares_in_public_off/ 2018-07-04T16:07:36+00:00 https://www.pharmaceutical-business-review.com/news/astellas-pharma-europe-tolmar-sign-license-agreement-for-eligard-170111/ 2018-07-04T16:07:37+00:00 https://www.pharmaceutical-business-review.com/news/icon-acquires-health-outcomes-consultancy-oxford-outcomes-170111/ 2018-07-04T16:07:37+00:00 https://www.pharmaceutical-business-review.com/news/callidus-software-forms-callidusrx-division-170111/ 2018-07-04T16:07:38+00:00 https://www.pharmaceutical-business-review.com/news/5a491covidien_and_purdue_pharma_resolve_patent_infringement_la/ 2018-07-04T16:07:38+00:00 https://www.pharmaceutical-business-review.com/news/7c48achelsea_initiates_dosing_in_second_phase_iii_study_of_hypotension/ 2018-07-04T16:07:38+00:00 https://www.pharmaceutical-business-review.com/news/biocryst-reports-influenza-drug-study-results-170111/ 2018-07-04T16:07:39+00:00 https://www.pharmaceutical-business-review.com/news/35485optimer_completes_enrollment_for_second_phase_iii_study_of_diarrhea/ 2018-07-04T16:07:39+00:00 https://www.pharmaceutical-business-review.com/news/5f496micromet_names_new_senior_vice_president_an/ 2018-07-04T16:07:39+00:00 https://www.pharmaceutical-business-review.com/news/10483akornstrides_wins_approval_for_two_new_/ 2018-07-04T16:07:39+00:00 https://www.pharmaceutical-business-review.com/news/dronedarone-associated-with-liver-injury-risk-fda-170111/ 2018-07-04T16:07:40+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-lupin-pharma-nabumetone-tablets-140311/ 2018-07-04T16:07:40+00:00 https://www.pharmaceutical-business-review.com/news/a14aetakeda_names_new_ceo_of_takeda_pharmaceuticals_e/ 2018-07-04T16:07:41+00:00 https://www.pharmaceutical-business-review.com/news/03483bayer_files_marketing_authorization_application_for_recombinant_human_thr/ 2018-07-04T16:07:41+00:00 https://www.pharmaceutical-business-review.com/news/2c4bbdaiichi_sankyo_reports_positive_data_for_anticoagulant/ 2018-07-04T16:07:41+00:00 https://www.pharmaceutical-business-review.com/news/144bbdr_reddys_wins_approval_for_generic_hypertension/ 2018-07-04T16:07:42+00:00 https://www.pharmaceutical-business-review.com/news/a0481cms_announces_initiation_of_cancer_treatment_with_monaco_s/ 2018-07-04T16:07:42+00:00 https://www.pharmaceutical-business-review.com/news/merck-makes-changes-in-vorapaxar-trials-140311/ 2018-07-04T16:07:42+00:00 https://www.pharmaceutical-business-review.com/news/orexo-invida-sign-supply-pact-140111/ 2018-07-04T16:07:42+00:00 https://www.pharmaceutical-business-review.com/news/774b9dubai_health_authority_launches_new_ne/ 2018-07-04T16:07:48+00:00 https://www.pharmaceutical-business-review.com/news/48496zymogenetics_receives_5_million_milestone_payment_from_bayer_healt/ 2018-07-04T16:07:48+00:00 https://www.pharmaceutical-business-review.com/news/ca484evotec_and_boehringer_achieve_third_milestone_in_drug_discovery_collabor/ 2018-07-04T16:07:48+00:00 https://www.pharmaceutical-business-review.com/news/pacira-pharma-releases-exparel-phase-3-bunionectomy-study-results-140111/ 2018-07-04T16:07:48+00:00 https://www.pharmaceutical-business-review.com/news/eisai-opens-sales-marketing-operation-in-netherlands-140111/ 2018-07-04T16:07:48+00:00 https://www.pharmaceutical-business-review.com/news/81489biosensors_reports_encouraging_results_from_cardiac_stent_comparison_/ 2018-07-04T16:07:49+00:00 https://www.pharmaceutical-business-review.com/news/0149fdebiopharm_and_epfl_sign_research_project_agre/ 2018-07-04T16:07:49+00:00 https://www.pharmaceutical-business-review.com/news/centice-introduces-computational-raman-technology-platform-140111/ 2018-07-04T16:07:50+00:00 https://www.pharmaceutical-business-review.com/news/idex-agrees-to-acquire-microfluidics-international-140111/ 2018-07-04T16:07:50+00:00 https://www.pharmaceutical-business-review.com/news/2749aoncolytics_initiates_us_phase_ii_lung_cancer_/ 2018-07-04T16:07:51+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-new-formulation-of-acetadote-injection-cumberland-pharma-140111/ 2018-07-04T16:07:51+00:00